kingcrayon的个人主页 - 老虎社区

kingcrayon

kingcrayon

暂无个人介绍

IP属地：未知

3关注

0粉丝

2主题

0勋章

2022-01-14

Love the headline *NASDAQ -2.51% 😂

Stocks rise as Wall Street shakes off red hot inflation report

2021-12-10

“Pops” it’s half a percent up AH 😂😂

OCGN Stock Pops on Key FDA News. Here’s What to Know.

2021-10-26

Total FUD spam, HTZZ just ordered 100,000 Tesla’s and TSLA just blew past $1,000 per share! ♥️ TSLA

抱歉，原内容已删除

2021-10-19

Did they mention UBS is shorting SPCE when they tell investors to sell?

Sell Virgin Galactic's stock after another long flight delay, UBS said

2021-09-03

Damn wish I had puts on this!

Forte Biosciences' shares fall 82% after scrapping development of FB-401 treatment

2021-09-01

As a Millennial with no generational wealth and learning saving your pay check doesn’t get you anywhere this is so true! Get rich or die trying!

抱歉，原内容已删除

2021-09-01

So WFC tanked big time today after this promotion 😂

抱歉，原内容已删除

2021-08-24

Ooooo so looking like DR Michael Burry is right.... bring on the puts!

Inside The Deterioration Of Tesla's Solar Business

2021-08-20

Ummmm the article right before this is the exact opposite headlined “something has got to give” in the stock market, warning of a crash........

抱歉，原内容已删除

2021-08-05

Ummmm so I brought puts on CCL because Delta was spreading—— and then it rallied up 16% in the 2days after

抱歉，原内容已删除

2021-08-03

Motley Fool I have learnt my lesson, I will be buying puts on these

抱歉，原内容已删除

2021-07-13

Tell me your opinion about this news...

SPI Energy stock jumps 17% on launching next generation electric pickup truck EF1-T

2021-06-16

Hurry up I have call options expiring

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3577554594597387","uuid":"3577554594597387","gmtCreate":1614460571610,"gmtModify":1623834915222,"name":"kingcrayon","pinyin":"kingcrayon","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":3,"tweetSize":13,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.02.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":694747411,"gmtCreate":1642141319751,"gmtModify":1642141813792,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577554594597387","idStr":"3577554594597387"},"themes":[],"htmlText":"Love the headline&nbsp;*NASDAQ -2.51% 😂","listText":"Love the headline&nbsp;*NASDAQ -2.51% 😂","text":"Love the headline *NASDAQ -2.51% 😂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/694747411","repostId":"1138592368","repostType":4,"repost":{"id":"1138592368","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641997842,"share":"https://www.laohu8.com/m/news/1138592368?lang=&edition=full","pubTime":"2022-01-12 22:30","market":"us","language":"en","title":"Stocks rise as Wall Street shakes off red hot inflation report","url":"https://stock-news.laohu8.com/highlight/detail?id=1138592368","media":"Tiger Newspress","summary":"Stocks rose Wednesday as investors eyed a new report on inflation, which showed another decades-high","content":"<html><head></head><body><p>Stocks rose Wednesday as investors eyed a new report on inflation, which showed another decades-high rate of price increases across the recovering economy. Still, this came a day following remarks from Federal Reserve Chair Jerome Powell reasserting that the central bank would step in as needed to rein in rising prices.</p><p>The Bureau of Labor Statistics&#39; December Consumer Price Index (CPI)showed prices rose at a 7.0% year-over-year rate at the end of 2021, marking the fastest increase since 1982. This matched consensus estimates, based on Bloomberg data, and accelerated from November&#39;s already elevated 6.8% increase. On a month-over-month basis, consumer prices rose 0.5%, or slightly more than the 0.4% rise expected, to mark an eighteenth consecutive month of prices increases.</p><p>Excluding food and energy prices, the so-called core measure of consumer prices rose 5.5% in December over last year, coming in at the fastest rate since 1991.</p><p>Wednesday&#39;s market moves came following a rebound rally on Tuesday, with markets at least temporarily finding relief in assurances from Federal Reserve Chair Jerome Powell that the central bank would step in as necessary to ease rising prices. InPowell&#39;s renomination hearing before the Senate Banking Committee, the central bank leader reiterated that the Fed would use its policy tools to bring down inflation.</p><p>“If we see inflation persisting at high levels, longer than expected, if we have to raise interest rates more over time, then we will,” Powell said during the hearing.</p><p>The central bankpreviously telegraphed it was eyeing three interest rate hikesthis year to bring benchmark rates up from their current near-zero levels. However, some topWall Street firms have predictedthe Fed will raise rates four times given the current inflationary backdrop.</p><p>But though Powell doubled down on the Fed&#39;s goal of curbing inflation and using interest rate hikes as a tool to achieve this, he revealed little further about the Fed&#39;s plan to begin shrinking its nearly $9 trillion balance sheet. The Fed&#39;s December meeting minutes last week suggested central bank officials were beginning to discuss drawing down the Fed&#39;s balance sheet after nearly two years of asset purchases to help support markets during the pandemic. Powell did reiterate in his hearing he expected the balance sheet runoff process would begin this year.</p><p>&#34;I think the biggest comment on most investors&#39; minds that we talk to around the world would be a &#39;policy mistake&#39; that the Fed might be too aggressive,&#34; Brian Belski, BMO Capital Markets chief investment strategist,told Yahoo Finance Live on Tuesday.&#34;Mr. Powell basically came out today and said this is going to be a process ... with respect to how long this is going to take, and I think that&#39;s what&#39;s calming investors.&#34;</p><p>Though prospects of higher borrowing costs and tighter financial conditions have stirred up volatility in U.S. equities and tech stocks especially in recent sessions, Tuesday&#39;s session saw a reversal, with the tech-heavy Nasdaq Composite sharply outperforming.</p><p>&#34;The issue with tech, I would argue, is not so much one of a little extra duration exposure because growth is further away, but it&#39;s simply one of valuation,&#34; Simeon Hyman, ProShares Global Investment Strategist,told Yahoo Finance Live on Tuesday.&#34;And indeed those top-heavy, largest-cap tech stocks perhaps just were a little bit expensive going into the end of last year and the beginning of 2022. But don&#39;t completely rule out good growth stories because that is the biggest defense against inflation. It is the growth of earnings and dividends.&#34;</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks rise as Wall Street shakes off red hot inflation report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks rise as Wall Street shakes off red hot inflation report\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-12 22:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Stocks rose Wednesday as investors eyed a new report on inflation, which showed another decades-high rate of price increases across the recovering economy. Still, this came a day following remarks from Federal Reserve Chair Jerome Powell reasserting that the central bank would step in as needed to rein in rising prices.</p><p>The Bureau of Labor Statistics&#39; December Consumer Price Index (CPI)showed prices rose at a 7.0% year-over-year rate at the end of 2021, marking the fastest increase since 1982. This matched consensus estimates, based on Bloomberg data, and accelerated from November&#39;s already elevated 6.8% increase. On a month-over-month basis, consumer prices rose 0.5%, or slightly more than the 0.4% rise expected, to mark an eighteenth consecutive month of prices increases.</p><p>Excluding food and energy prices, the so-called core measure of consumer prices rose 5.5% in December over last year, coming in at the fastest rate since 1991.</p><p>Wednesday&#39;s market moves came following a rebound rally on Tuesday, with markets at least temporarily finding relief in assurances from Federal Reserve Chair Jerome Powell that the central bank would step in as necessary to ease rising prices. InPowell&#39;s renomination hearing before the Senate Banking Committee, the central bank leader reiterated that the Fed would use its policy tools to bring down inflation.</p><p>“If we see inflation persisting at high levels, longer than expected, if we have to raise interest rates more over time, then we will,” Powell said during the hearing.</p><p>The central bankpreviously telegraphed it was eyeing three interest rate hikesthis year to bring benchmark rates up from their current near-zero levels. However, some topWall Street firms have predictedthe Fed will raise rates four times given the current inflationary backdrop.</p><p>But though Powell doubled down on the Fed&#39;s goal of curbing inflation and using interest rate hikes as a tool to achieve this, he revealed little further about the Fed&#39;s plan to begin shrinking its nearly $9 trillion balance sheet. The Fed&#39;s December meeting minutes last week suggested central bank officials were beginning to discuss drawing down the Fed&#39;s balance sheet after nearly two years of asset purchases to help support markets during the pandemic. Powell did reiterate in his hearing he expected the balance sheet runoff process would begin this year.</p><p>&#34;I think the biggest comment on most investors&#39; minds that we talk to around the world would be a &#39;policy mistake&#39; that the Fed might be too aggressive,&#34; Brian Belski, BMO Capital Markets chief investment strategist,told Yahoo Finance Live on Tuesday.&#34;Mr. Powell basically came out today and said this is going to be a process ... with respect to how long this is going to take, and I think that&#39;s what&#39;s calming investors.&#34;</p><p>Though prospects of higher borrowing costs and tighter financial conditions have stirred up volatility in U.S. equities and tech stocks especially in recent sessions, Tuesday&#39;s session saw a reversal, with the tech-heavy Nasdaq Composite sharply outperforming.</p><p>&#34;The issue with tech, I would argue, is not so much one of a little extra duration exposure because growth is further away, but it&#39;s simply one of valuation,&#34; Simeon Hyman, ProShares Global Investment Strategist,told Yahoo Finance Live on Tuesday.&#34;And indeed those top-heavy, largest-cap tech stocks perhaps just were a little bit expensive going into the end of last year and the beginning of 2022. But don&#39;t completely rule out good growth stories because that is the biggest defense against inflation. It is the growth of earnings and dividends.&#34;</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138592368","content_text":"Stocks rose Wednesday as investors eyed a new report on inflation, which showed another decades-high rate of price increases across the recovering economy. Still, this came a day following remarks from Federal Reserve Chair Jerome Powell reasserting that the central bank would step in as needed to rein in rising prices.The Bureau of Labor Statistics' December Consumer Price Index (CPI)showed prices rose at a 7.0% year-over-year rate at the end of 2021, marking the fastest increase since 1982. This matched consensus estimates, based on Bloomberg data, and accelerated from November's already elevated 6.8% increase. On a month-over-month basis, consumer prices rose 0.5%, or slightly more than the 0.4% rise expected, to mark an eighteenth consecutive month of prices increases.Excluding food and energy prices, the so-called core measure of consumer prices rose 5.5% in December over last year, coming in at the fastest rate since 1991.Wednesday's market moves came following a rebound rally on Tuesday, with markets at least temporarily finding relief in assurances from Federal Reserve Chair Jerome Powell that the central bank would step in as necessary to ease rising prices. InPowell's renomination hearing before the Senate Banking Committee, the central bank leader reiterated that the Fed would use its policy tools to bring down inflation.“If we see inflation persisting at high levels, longer than expected, if we have to raise interest rates more over time, then we will,” Powell said during the hearing.The central bankpreviously telegraphed it was eyeing three interest rate hikesthis year to bring benchmark rates up from their current near-zero levels. However, some topWall Street firms have predictedthe Fed will raise rates four times given the current inflationary backdrop.But though Powell doubled down on the Fed's goal of curbing inflation and using interest rate hikes as a tool to achieve this, he revealed little further about the Fed's plan to begin shrinking its nearly $9 trillion balance sheet. The Fed's December meeting minutes last week suggested central bank officials were beginning to discuss drawing down the Fed's balance sheet after nearly two years of asset purchases to help support markets during the pandemic. Powell did reiterate in his hearing he expected the balance sheet runoff process would begin this year.\"I think the biggest comment on most investors' minds that we talk to around the world would be a 'policy mistake' that the Fed might be too aggressive,\" Brian Belski, BMO Capital Markets chief investment strategist,told Yahoo Finance Live on Tuesday.\"Mr. Powell basically came out today and said this is going to be a process ... with respect to how long this is going to take, and I think that's what's calming investors.\"Though prospects of higher borrowing costs and tighter financial conditions have stirred up volatility in U.S. equities and tech stocks especially in recent sessions, Tuesday's session saw a reversal, with the tech-heavy Nasdaq Composite sharply outperforming.\"The issue with tech, I would argue, is not so much one of a little extra duration exposure because growth is further away, but it's simply one of valuation,\" Simeon Hyman, ProShares Global Investment Strategist,told Yahoo Finance Live on Tuesday.\"And indeed those top-heavy, largest-cap tech stocks perhaps just were a little bit expensive going into the end of last year and the beginning of 2022. But don't completely rule out good growth stories because that is the biggest defense against inflation. It is the growth of earnings and dividends.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":528,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605928154,"gmtCreate":1639103338852,"gmtModify":1639103436390,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577554594597387","idStr":"3577554594597387"},"themes":[],"htmlText":"“Pops” it’s half a percent up AH 😂😂","listText":"“Pops” it’s half a percent up AH 😂😂","text":"“Pops” it’s half a percent up AH 😂😂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605928154","repostId":"1186120067","repostType":4,"repost":{"id":"1186120067","pubTimestamp":1639102922,"share":"https://www.laohu8.com/m/news/1186120067?lang=&edition=full","pubTime":"2021-12-10 10:22","market":"us","language":"en","title":"OCGN Stock Pops on Key FDA News. Here’s What to Know.","url":"https://stock-news.laohu8.com/highlight/detail?id=1186120067","media":"InvestorPlace","summary":"Biopharmaceutical company Ocugen(NASDAQ:OCGN) announced today that the U.S. Food and Drug Administra","content":"<p>Biopharmaceutical company&nbsp;<b>Ocugen</b>(NASDAQ:<b><u>OCGN</u></b>) announced today that the U.S. Food and Drug Administration (FDA) approved the company’s Investigational New Drug (IND) application for a human clinical trial of OCU400. OCU400 is a gene-therapy candidate targeting several degenerative eye diseases that severely impair vision. Despite the news, OCGN stock is down 6.3% today as investors seem reluctant to buy into the struggling med-tech company.</p>\n<p>Shankar Musunuri, chief executive and co-founder of Ocugen, commented on&nbsp;the significance of this recent development.</p>\n<blockquote>\n <i>“We are delighted to advance OCU400 into clinical trials, which exemplifies our goal of offering new options to people with genetic diseases where none currently exist. … We’re collaborating with leading centers in eye care and have been vital partners to getting our trial launched and receive patients. With this final decision by the FDA, we are embarking on a new pathway of care through this innovative gene therapy.”</i>\n</blockquote>\n<p>The news comes as a welcome change of pace for the company. Ocugen is perhaps best known for its Covid-19 vaccine Covaxin, which largely lags behind the competition. On Nov. 30, the FDA&nbsp;issued a hold&nbsp;on an approval application for late-stage clinical testing of its vaccine.</p>\n<p>Ocugen represents just the North American side of the vaccine’s distribution. Meanwhile,&nbsp;<b>Bharat Biotech</b>, co-developer of the vaccine, has earned approval for use in 17 countries, including the company’s native India. This stands in stark contrast to Ocugen, who many investors believe is&nbsp;too little too late. Ocugen has come under fire for attempting to penetrate largely saturated Western markets as it pertains to vaccine options.</p>\n<p>Will this latest news shake things up for the struggling pharma company?</p>\n<p>OCU400: A Silver Lining for Struggling OCGN stock</p>\n<p>Arguably, OCU400 is Ocugen’s main prize-horse going forward. Anticipation surrounding the company’s breakthrough gene-therapy programs has taken OCGN stock to the moon and back in the past few years. However, that anticipation has largely died down. With many estimating it could be years before such a therapy hits the market, combined with seemingly constant roadblocks for its vaccine candidate, OCGN stock has been on a cold streak for quite a while. Therefore, this news should come as a breath of fresh air for OCGN investors.</p>\n<p>Preliminary estimates see OCU400 being a completely novel solution to a series of retinal degenerative diseases. This year, the European Medicines Agency (EMA) even granted OCU400 a broad medical designation&nbsp;for two different optical diseases.</p>\n<p>While investors currently seem hesitant, hope isn’t lost yet. Positive developments of this nature can create the positive momentum necessary to bring the stock back from the dead.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OCGN Stock Pops on Key FDA News. Here’s What to Know.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOCGN Stock Pops on Key FDA News. Here’s What to Know.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-10 10:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/ocgn-stock-pops-on-key-fda-news-heres-what-to-know/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biopharmaceutical company Ocugen(NASDAQ:OCGN) announced today that the U.S. Food and Drug Administration (FDA) approved the company’s Investigational New Drug (IND) application for a human clinical ...</p>\n\n<a href=\"https://investorplace.com/2021/12/ocgn-stock-pops-on-key-fda-news-heres-what-to-know/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://investorplace.com/2021/12/ocgn-stock-pops-on-key-fda-news-heres-what-to-know/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186120067","content_text":"Biopharmaceutical company Ocugen(NASDAQ:OCGN) announced today that the U.S. Food and Drug Administration (FDA) approved the company’s Investigational New Drug (IND) application for a human clinical trial of OCU400. OCU400 is a gene-therapy candidate targeting several degenerative eye diseases that severely impair vision. Despite the news, OCGN stock is down 6.3% today as investors seem reluctant to buy into the struggling med-tech company.\nShankar Musunuri, chief executive and co-founder of Ocugen, commented on the significance of this recent development.\n\n“We are delighted to advance OCU400 into clinical trials, which exemplifies our goal of offering new options to people with genetic diseases where none currently exist. … We’re collaborating with leading centers in eye care and have been vital partners to getting our trial launched and receive patients. With this final decision by the FDA, we are embarking on a new pathway of care through this innovative gene therapy.”\n\nThe news comes as a welcome change of pace for the company. Ocugen is perhaps best known for its Covid-19 vaccine Covaxin, which largely lags behind the competition. On Nov. 30, the FDA issued a hold on an approval application for late-stage clinical testing of its vaccine.\nOcugen represents just the North American side of the vaccine’s distribution. Meanwhile, Bharat Biotech, co-developer of the vaccine, has earned approval for use in 17 countries, including the company’s native India. This stands in stark contrast to Ocugen, who many investors believe is too little too late. Ocugen has come under fire for attempting to penetrate largely saturated Western markets as it pertains to vaccine options.\nWill this latest news shake things up for the struggling pharma company?\nOCU400: A Silver Lining for Struggling OCGN stock\nArguably, OCU400 is Ocugen’s main prize-horse going forward. Anticipation surrounding the company’s breakthrough gene-therapy programs has taken OCGN stock to the moon and back in the past few years. However, that anticipation has largely died down. With many estimating it could be years before such a therapy hits the market, combined with seemingly constant roadblocks for its vaccine candidate, OCGN stock has been on a cold streak for quite a while. Therefore, this news should come as a breath of fresh air for OCGN investors.\nPreliminary estimates see OCU400 being a completely novel solution to a series of retinal degenerative diseases. This year, the European Medicines Agency (EMA) even granted OCU400 a broad medical designation for two different optical diseases.\nWhile investors currently seem hesitant, hope isn’t lost yet. Positive developments of this nature can create the positive momentum necessary to bring the stock back from the dead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":366,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856229063,"gmtCreate":1635186675323,"gmtModify":1635209304258,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577554594597387","idStr":"3577554594597387"},"themes":[],"htmlText":"Total FUD spam, HTZZ just ordered 100,000 Tesla’s and TSLA just blew past $1,000 per share! ♥️ TSLA","listText":"Total FUD spam, HTZZ just ordered 100,000 Tesla’s and TSLA just blew past $1,000 per share! ♥️ TSLA","text":"Total FUD spam, HTZZ just ordered 100,000 Tesla’s and TSLA just blew past $1,000 per share! ♥️ TSLA","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856229063","repostId":"2178427008","repostType":2,"isVote":1,"tweetType":1,"viewCount":690,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850604980,"gmtCreate":1634586078839,"gmtModify":1634608846648,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577554594597387","idStr":"3577554594597387"},"themes":[],"htmlText":"Did they mention UBS is shorting SPCE when they tell investors to sell?&nbsp;","listText":"Did they mention UBS is shorting SPCE when they tell investors to sell?&nbsp;","text":"Did they mention UBS is shorting SPCE when they tell investors to sell?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850604980","repostId":"2176798122","repostType":2,"repost":{"id":"2176798122","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1634576220,"share":"https://www.laohu8.com/m/news/2176798122?lang=&edition=full","pubTime":"2021-10-19 00:57","market":"hk","language":"en","title":"Sell Virgin Galactic's stock after another long flight delay, UBS said","url":"https://stock-news.laohu8.com/highlight/detail?id=2176798122","media":"Dow Jones","summary":"MW Sell Virgin Galactic's stock after another long flight delay, UBS said\n\n\n  Tomi Kilgore \n\n\n  In f","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Sell Virgin Galactic's stock after another long flight delay, UBS said\n</p>\n<p>\n  Tomi Kilgore \n</p>\n<p>\n  In five months, Analyst Myles Walton has swung to bearish from bullish while the stock had gone full circle \n</p>\n<p>\n  Shares of Virgin Galactic dove Monday toward a five-month low, after UBS analyst Myles Walton recommended investors sell, after another \"long pushout\" of revenue-generating test flights was announced just weeks before of a large chuck of shares becomes available for sale. \n</p>\n<p>\n  Walton downgraded the space-tourism company to sell, after being at neutral since July 5. He slashed his stock price target by 42%, to $15 from $26. The new target implied a further 24% downside from current levels. \n</p>\n<p>\n  The stock <a href=\"https://laohu8.com/S/SPCE\">$(SPCE)$</a> dropped as much as 5.0% to an intraday low of $19.00, before paring some losses to be down 1.2% in midday trading. It has now shed 64.6% since closing at a four-month high of $55.91 on June 25. \n</p>\n<p>\n  The downgrade comes <a href=\"https://laohu8.com/S/AONE.U\">one</a> session after the stock tumbled 16.8%, following the company's announcement that commercial space flights would not begin until late 2022 after an issue with some materials was found. Walton noted that announcement was made just about a month after the company had delayed a powered flight to late October from late September because of a supplier part issue. \n</p>\n<p>\n  Don't miss: Virgin Galactic announces another delay, and the stock is plunging. \n</p>\n<p>\n  Walton said that although the company is certainly taking the right step to keep safety first, the \"starts and stops\" of flights, coupled with longer turn times of current generation spaceships shows the difficulty in providing investors with predictable and reliable operations. \n</p>\n<p>\n  \"The event path for the stock is now disjointed for the better part of the next year, and with 24% of shares outstanding (32% of the float) exiting their lockup period at the end of the month we expect further pressure ahead for the stock,\" Walton wrote in a note to clients. \n</p>\n<p>\n  Walton has now swung from bullish to bearish on the stock in five months, over a time that the stock had nearly tripled then lost all of those gains, and then some. \n</p>\n<p>\n  He had downgraded the stock to neutral from buy on July 6, while raising his price target to $45 from $36, citing valuation after the stock had more than doubled in a little over a month. That followed Walton's upgrade of the stock to buy from neutral on May 20, but trimmed his price target to $36 from $40, saying that valuation was now attractive as investor fears over test-flight delays and competitive pressures were overblown. \n</p>\n<p>\n  The fact that most of the remaining insider stakes were locked up through October was another reason to be bullish. (A lockup refers to an agreement by insiders not to sell the shares they own for a previously agreed upon time.) \n</p>\n<p>\n  Interestingly, the stock closed on the day Walton turned bullish at $19.81, or just 0.2% above current levels. \n</p>\n<p>\n  In Monday's note, he said with the start of commercial operations pushed out to the fourth quarter of 2022, it moves the cumulative delay to 2 1/2 years from the mid-2020 target the company had when it went public two years ago. \n</p>\n<p>\n  \"With a cumulative delay longer than the time the company has been public, it'll be a challenge to get too optimistic on flight cadence, and we've further lowered our outyear trajectory,\" Walton wrote. \n</p>\n<p>\n  The stock has now tumbled 34.5% over the past three months, and has shed 11.9% over the past 12 months. In comparison, the S&amp;P 500 index  has gained 3.5% the past three months and soared 28.6% the past year. \n</p>\n<p>\n  -Tomi Kilgore \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  October 18, 2021 12:57 ET (16:57 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sell Virgin Galactic's stock after another long flight delay, UBS said</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSell Virgin Galactic's stock after another long flight delay, UBS said\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-10-19 00:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Sell Virgin Galactic's stock after another long flight delay, UBS said\n</p>\n<p>\n  Tomi Kilgore \n</p>\n<p>\n  In five months, Analyst Myles Walton has swung to bearish from bullish while the stock had gone full circle \n</p>\n<p>\n  Shares of Virgin Galactic dove Monday toward a five-month low, after UBS analyst Myles Walton recommended investors sell, after another \"long pushout\" of revenue-generating test flights was announced just weeks before of a large chuck of shares becomes available for sale. \n</p>\n<p>\n  Walton downgraded the space-tourism company to sell, after being at neutral since July 5. He slashed his stock price target by 42%, to $15 from $26. The new target implied a further 24% downside from current levels. \n</p>\n<p>\n  The stock <a href=\"https://laohu8.com/S/SPCE\">$(SPCE)$</a> dropped as much as 5.0% to an intraday low of $19.00, before paring some losses to be down 1.2% in midday trading. It has now shed 64.6% since closing at a four-month high of $55.91 on June 25. \n</p>\n<p>\n  The downgrade comes <a href=\"https://laohu8.com/S/AONE.U\">one</a> session after the stock tumbled 16.8%, following the company's announcement that commercial space flights would not begin until late 2022 after an issue with some materials was found. Walton noted that announcement was made just about a month after the company had delayed a powered flight to late October from late September because of a supplier part issue. \n</p>\n<p>\n  Don't miss: Virgin Galactic announces another delay, and the stock is plunging. \n</p>\n<p>\n  Walton said that although the company is certainly taking the right step to keep safety first, the \"starts and stops\" of flights, coupled with longer turn times of current generation spaceships shows the difficulty in providing investors with predictable and reliable operations. \n</p>\n<p>\n  \"The event path for the stock is now disjointed for the better part of the next year, and with 24% of shares outstanding (32% of the float) exiting their lockup period at the end of the month we expect further pressure ahead for the stock,\" Walton wrote in a note to clients. \n</p>\n<p>\n  Walton has now swung from bullish to bearish on the stock in five months, over a time that the stock had nearly tripled then lost all of those gains, and then some. \n</p>\n<p>\n  He had downgraded the stock to neutral from buy on July 6, while raising his price target to $45 from $36, citing valuation after the stock had more than doubled in a little over a month. That followed Walton's upgrade of the stock to buy from neutral on May 20, but trimmed his price target to $36 from $40, saying that valuation was now attractive as investor fears over test-flight delays and competitive pressures were overblown. \n</p>\n<p>\n  The fact that most of the remaining insider stakes were locked up through October was another reason to be bullish. (A lockup refers to an agreement by insiders not to sell the shares they own for a previously agreed upon time.) \n</p>\n<p>\n  Interestingly, the stock closed on the day Walton turned bullish at $19.81, or just 0.2% above current levels. \n</p>\n<p>\n  In Monday's note, he said with the start of commercial operations pushed out to the fourth quarter of 2022, it moves the cumulative delay to 2 1/2 years from the mid-2020 target the company had when it went public two years ago. \n</p>\n<p>\n  \"With a cumulative delay longer than the time the company has been public, it'll be a challenge to get too optimistic on flight cadence, and we've further lowered our outyear trajectory,\" Walton wrote. \n</p>\n<p>\n  The stock has now tumbled 34.5% over the past three months, and has shed 11.9% over the past 12 months. In comparison, the S&amp;P 500 index  has gained 3.5% the past three months and soared 28.6% the past year. \n</p>\n<p>\n  -Tomi Kilgore \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  October 18, 2021 12:57 ET (16:57 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"USB":"美国合众银行","SPCE":"维珍银河"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176798122","content_text":"MW Sell Virgin Galactic's stock after another long flight delay, UBS said\n\n\n  Tomi Kilgore \n\n\n  In five months, Analyst Myles Walton has swung to bearish from bullish while the stock had gone full circle \n\n\n  Shares of Virgin Galactic dove Monday toward a five-month low, after UBS analyst Myles Walton recommended investors sell, after another \"long pushout\" of revenue-generating test flights was announced just weeks before of a large chuck of shares becomes available for sale. \n\n\n  Walton downgraded the space-tourism company to sell, after being at neutral since July 5. He slashed his stock price target by 42%, to $15 from $26. The new target implied a further 24% downside from current levels. \n\n\n  The stock $(SPCE)$ dropped as much as 5.0% to an intraday low of $19.00, before paring some losses to be down 1.2% in midday trading. It has now shed 64.6% since closing at a four-month high of $55.91 on June 25. \n\n\n  The downgrade comes one session after the stock tumbled 16.8%, following the company's announcement that commercial space flights would not begin until late 2022 after an issue with some materials was found. Walton noted that announcement was made just about a month after the company had delayed a powered flight to late October from late September because of a supplier part issue. \n\n\n  Don't miss: Virgin Galactic announces another delay, and the stock is plunging. \n\n\n  Walton said that although the company is certainly taking the right step to keep safety first, the \"starts and stops\" of flights, coupled with longer turn times of current generation spaceships shows the difficulty in providing investors with predictable and reliable operations. \n\n\n  \"The event path for the stock is now disjointed for the better part of the next year, and with 24% of shares outstanding (32% of the float) exiting their lockup period at the end of the month we expect further pressure ahead for the stock,\" Walton wrote in a note to clients. \n\n\n  Walton has now swung from bullish to bearish on the stock in five months, over a time that the stock had nearly tripled then lost all of those gains, and then some. \n\n\n  He had downgraded the stock to neutral from buy on July 6, while raising his price target to $45 from $36, citing valuation after the stock had more than doubled in a little over a month. That followed Walton's upgrade of the stock to buy from neutral on May 20, but trimmed his price target to $36 from $40, saying that valuation was now attractive as investor fears over test-flight delays and competitive pressures were overblown. \n\n\n  The fact that most of the remaining insider stakes were locked up through October was another reason to be bullish. (A lockup refers to an agreement by insiders not to sell the shares they own for a previously agreed upon time.) \n\n\n  Interestingly, the stock closed on the day Walton turned bullish at $19.81, or just 0.2% above current levels. \n\n\n  In Monday's note, he said with the start of commercial operations pushed out to the fourth quarter of 2022, it moves the cumulative delay to 2 1/2 years from the mid-2020 target the company had when it went public two years ago. \n\n\n  \"With a cumulative delay longer than the time the company has been public, it'll be a challenge to get too optimistic on flight cadence, and we've further lowered our outyear trajectory,\" Walton wrote. \n\n\n  The stock has now tumbled 34.5% over the past three months, and has shed 11.9% over the past 12 months. In comparison, the S&P 500 index  has gained 3.5% the past three months and soared 28.6% the past year. \n\n\n  -Tomi Kilgore \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  October 18, 2021 12:57 ET (16:57 GMT)\n\n\n  Copyright (c) 2021 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":505,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":812754922,"gmtCreate":1630626922066,"gmtModify":1630634981855,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577554594597387","idStr":"3577554594597387"},"themes":[],"htmlText":"Damn wish I had puts on this!&nbsp;","listText":"Damn wish I had puts on this!&nbsp;","text":"Damn wish I had puts on this!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/812754922","repostId":"1186835624","repostType":2,"repost":{"id":"1186835624","pubTimestamp":1630625981,"share":"https://www.laohu8.com/m/news/1186835624?lang=&edition=full","pubTime":"2021-09-03 07:39","market":"us","language":"en","title":"Forte Biosciences' shares fall 82% after scrapping development of FB-401 treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1186835624","media":"seekingalpha","summary":"Forte Biosciences announces that it will not continue to advance the development of its atopic derma","content":"<p>Forte Biosciences&nbsp;announces that it&nbsp;will not continue to advance the development of its atopic dermatitis treatment FB-401 following mid-stage trial results.</p>\n<p>Shares slide nearly&nbsp;82%&nbsp;post market.</p>\n<p><img src=\"https://static.tigerbbs.com/ba305cccf4317784780adcba0d37993e\" tg-width=\"1020\" tg-height=\"522\" width=\"100%\" height=\"auto\"></p>\n<p>In the phase 2 study, the drug failed to meet statistical significance for the primary endpoint of EASI-50 (the proportion of patients with at least a 50% improvement in atopic dermatitis disease severity as measure by EASI), the company said.</p>\n<p>\"The topline data is disappointing and we will continue to analyze the data; however, given this readout we will not continue to advance FB-401,\" CEO Paul Wagner said.</p>\n<p>Forte Biosciences previously reported that it had cash and cash equivalents of $50.8M as of June 30, 2021.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forte Biosciences' shares fall 82% after scrapping development of FB-401 treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForte Biosciences' shares fall 82% after scrapping development of FB-401 treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-03 07:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3736993-forte-biosciences-shares-fall-12-after-scrapping-development-of-fb-401-treatment><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Forte Biosciences announces that it will not continue to advance the development of its atopic dermatitis treatment FB-401 following mid-stage trial results.\nShares slide nearly 82% post market.\n\nIn ...</p>\n\n<a href=\"https://seekingalpha.com/news/3736993-forte-biosciences-shares-fall-12-after-scrapping-development-of-fb-401-treatment\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FBRX":"Forte BioSciences Inc"},"source_url":"https://seekingalpha.com/news/3736993-forte-biosciences-shares-fall-12-after-scrapping-development-of-fb-401-treatment","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1186835624","content_text":"Forte Biosciences announces that it will not continue to advance the development of its atopic dermatitis treatment FB-401 following mid-stage trial results.\nShares slide nearly 82% post market.\n\nIn the phase 2 study, the drug failed to meet statistical significance for the primary endpoint of EASI-50 (the proportion of patients with at least a 50% improvement in atopic dermatitis disease severity as measure by EASI), the company said.\n\"The topline data is disappointing and we will continue to analyze the data; however, given this readout we will not continue to advance FB-401,\" CEO Paul Wagner said.\nForte Biosciences previously reported that it had cash and cash equivalents of $50.8M as of June 30, 2021.","news_type":1},"isVote":1,"tweetType":1,"viewCount":269,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":816611661,"gmtCreate":1630495252853,"gmtModify":1630495602949,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577554594597387","idStr":"3577554594597387"},"themes":[],"htmlText":"As a Millennial with no generational wealth and learning saving your pay check doesn’t get you anywhere this is so true! Get rich or die trying!&nbsp;","listText":"As a Millennial with no generational wealth and learning saving your pay check doesn’t get you anywhere this is so true! Get rich or die trying!&nbsp;","text":"As a Millennial with no generational wealth and learning saving your pay check doesn’t get you anywhere this is so true! Get rich or die trying!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/816611661","repostId":"1128788292","repostType":4,"isVote":1,"tweetType":1,"viewCount":514,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818476415,"gmtCreate":1630444487137,"gmtModify":1630462084987,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577554594597387","idStr":"3577554594597387"},"themes":[],"htmlText":"So WFC tanked big time today after this promotion 😂","listText":"So WFC tanked big time today after this promotion 😂","text":"So WFC tanked big time today after this promotion 😂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/818476415","repostId":"1153871779","repostType":2,"isVote":1,"tweetType":1,"viewCount":323,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834887837,"gmtCreate":1629790224529,"gmtModify":1629795484786,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577554594597387","idStr":"3577554594597387"},"themes":[],"htmlText":"Ooooo so looking like DR&nbsp;Michael Burry is right.... bring on the puts!&nbsp;","listText":"Ooooo so looking like DR&nbsp;Michael Burry is right.... bring on the puts!&nbsp;","text":"Ooooo so looking like DR Michael Burry is right.... bring on the puts!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/834887837","repostId":"1187997976","repostType":4,"repost":{"id":"1187997976","pubTimestamp":1629777349,"share":"https://www.laohu8.com/m/news/1187997976?lang=&edition=full","pubTime":"2021-08-24 11:55","market":"us","language":"en","title":"Inside The Deterioration Of Tesla's Solar Business","url":"https://stock-news.laohu8.com/highlight/detail?id=1187997976","media":"seekingalpha","summary":"Tesla's $670 billion market cap is based in part on the belief that it is \"more than a car company\"; Tesla's solar energy business has fed this narrative.While treated like a value-add by Tesla's boosters, its solar unit has in practice been a costly millstone; margins remain deeply negative.Tesla's solar deployments have fallen far from highs set years ago, with little prospect of a reversal.Hopes that Tesla's Solar Roof could reinvigorate deployment rates have faded amid multi-year delays and ","content":"<p>Summary</p>\n<ul>\n <li>Tesla's $670 billion market cap is based in part on the belief that it is \"more than a car company\"; Tesla's solar energy business has fed this narrative.</li>\n <li>While treated like a value-add by Tesla's boosters, its solar unit has in practice been a costly millstone; margins remain deeply negative.</li>\n <li>Tesla's solar deployments have fallen far from highs set years ago, with little prospect of a reversal.</li>\n <li>Hopes that Tesla's Solar Roof could reinvigorate deployment rates have faded amid multi-year delays and persistent installation bottlenecks.</li>\n <li>As Tesla's solar business fades, it may threaten the company's broader growth narrative, as well as its vaunted share price.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b04b99e933e100452f6e47f2c34a1460\" tg-width=\"768\" tg-height=\"512\" width=\"100%\" height=\"auto\"><span>RoschetzkyIstockPhoto/iStock Editorial via Getty Images</span></p>\n<p>As any of my longtime readers can undoubtedly attest, I have been tracking Tesla Inc. (NASDAQ:TSLA) for a while. I have covered numerous subjects related to the electric vehicle (“EV”) company over the years, but I have returned often to one in particular: Tesla’s solar energy business.</p>\n<p>It has been a while since I lasttook a look under the hoodof Tesla’s solar division. With the first two quarters of 2021 in the rearview mirror, it feels like now is a good time to revisit the long-struggling business unit.</p>\n<p>Much has changed for Tesla Solar in 2021, little of it for the good. Let’s discuss why this is the case.</p>\n<p>Solar Deployments In H1 2021: Still In A Long-Term Downtrend</p>\n<p>As I have&nbsp;discussed at length&nbsp;on&nbsp;numerous occasions&nbsp;over the years, Tesla Solar has been in material multi-year decline from a deployments perspective. Thus, when Tesla reported Q1 2021 earnings, I naturally looked to the solar deployment numbers to see if the negative pattern had continued. As it turned out, Tesla had managed to achieve a major sequential jump in deployments, a fact the company was quick tocrow about in its Q1 investor letter:</p>\n<blockquote>\n “Solar Retrofit and Solar Roof Solar deployments reached 92 MW in Q1, our strongest quarter in 2.5 years. Solar Roof deployments grew 9x compared to the same period last year.”\n</blockquote>\n<p>Tesla reported solar deployments to the tune of 92 megawatts (“MW”) in Q1, the most it had managed in years. Under the circumstances, Tesla can hardly be blamed for having wanted to highlight such a marked improvement in chart form:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7270ea980168a8e2976a38fd80b6b5c7\" tg-width=\"640\" tg-height=\"335\" width=\"100%\" height=\"auto\"><span>Source: Tesla Inc.</span></p>\n<p>The chart above, which was included in the Q1 investor letter, certainly looks like it could be a sign of a turnaround in the making. However, its relatively limited timescale also limits its usefulness to investors and analysts interested in understanding the long-term performance and trajectory of Tesla's solar business. Charting the full history of Tesla's quarterly solar deployments through Q1 2021 offers a rather different perspective:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/dab180dd817e9d4db21ed6ff4014e0d7\" tg-width=\"640\" tg-height=\"273\" width=\"100%\" height=\"auto\"><span>Source: Author; Tesla Inc.</span></p>\n<p>I hardly have to remind investors that one quarter of growth does not a pattern make. If Tesla could sustain that growth into Q2, then one might be able to talk legitimately about a turnaround. As it turned out, Tesladeployed just 85 MW in Q2, a more than7.5% sequential drop:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/43e076db4124ae5b339c1c78e6f33502\" tg-width=\"640\" tg-height=\"463\" width=\"100%\" height=\"auto\"><span>Source: TeslaCharts; Tesla Inc.</span></p>\n<p>Tesla's solar deployments were not just lower in Q2 than in Q1, however. At 85MW, Tesla actually managed one 1MW less than it did in Q4 2020, despite seasonal impacts traditionally weakening year-end solar deployment rates. That would seem to put paid to any notion that Tesla's solar operations have been making a significant or sustainable turnaround.</p>\n<p>Deployments may have climbed significantly from their nadir in the first half of last year, but they remain a pale shadow of what Tesla was managing five years ago. They are also radically lower than what Tesla itself hadprojected in 2016when it was in the process of acquiring SolarCity:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a0a31640e43eea612f1ca8aba8bea3ae\" tg-width=\"498\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Source: @C_S_Skeptic; GLJ Research; Tesla Inc.</span></p>\n<p>In 2016, Tesla was predicting solar deployments in excess of 500MW per quarter starting in 2017. We are now mid-way through 2021 and quarterly solar deployment levels stand at less than 20% of that figure.</p>\n<p>Product Progress: Solar Roof Still Not Ready For Prime Time</p>\n<p>Unveiled with great fanfare in October 2016,the Solar Roof was touted from the start as the future of solar energy technology. At the time, CEO Elon Musk was insistent that the Solar Roof was not merely a concept in development, but was actually a fully functional technology ready to enter full-scale production. Musk told his rapt audience that the acquisition of SolarCity would facilitate the rapid rollout of the Solar Roof, providing one of the first public justifications for the merger between Tesla and the virtually insolvent solar installer that had been founded by two of Musk's cousins, and of which Musk was then chairman of the board of directors.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e0e6430233a156f81e842006c4eac751\" tg-width=\"640\" tg-height=\"302\" width=\"100%\" height=\"auto\"><span>Source: Tesla Inc.</span></p>\n<p>The Solar Roof unveiling event may have helped smooth the way for the SolarCity tie-up, but it did so at the price of full transparency about the technology's readiness. Musk's claim about the Solar Roof's immediate viability was proven false in short order, as it quickly became apparent that the Solar Roof was still very much a concept in development, and with little near-term prospect of commercialization. Even then, few could have guessed how long that design and development process would take.</p>\n<p>A review of the progress to date on the long-promised but oft-delayed Solar Roof reveals a business reality far different from what has long been promised by Tesla’s solar cheerleaders. In the years since it was unveiled, the Solar Roof has gone through multipleredesigns and rebrands, even as Musk has repeatedly assured investors and the public that full-scale commercial production was imminent. In March 2019, he declared that 2019 would be \"the Year of the Solar Roof.\" In July of the same year, Musk tweeted that Solar Roof production wasaccelerating toward 1,000 units roofs per week:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6bbff17a88092785ef1227e94c6e8f19\" tg-width=\"640\" tg-height=\"251\" width=\"100%\" height=\"auto\"><span>Source: Elon Musk; Twitter</span></p>\n<p>This claim raised plenty of eyebrows in the investment community. Their skepticism proved well deserved as it soon became apparent that the actual Solar Roof production and installation rates were far lower. Even Electrek, a website well known for its consistently bullish Tesla commentary, felt compelled to call Musk out on his claim. According to Electrek, Musk's tweet was \"a bit of an exaggeration\" and that the actual production rate at the time was closer to 500 Solar Roofs per week. However, even that reduced projection appears to overstate the level of steady-state production and installation by a significant margin.</p>\n<p>The Solar Roof has seen its fortunes improve little in 2021 thus far. According to renewable energy industry journalist Eric Wesoff, Tesla had&nbsp;yet to install 1,000 Solar Roofs total&nbsp;as recently as this April. This pessimistic view was further reinforced last month when the Wall Street Journal&nbsp;reported&nbsp;that the Securities and Exchange Commission had already confronted Tesla over Musk's dubious prior Solar Roof claims:</p>\n<blockquote>\n “In correspondence sent to Tesla in 2019 and 2020, the SEC said tweets Mr. Musk wrote about Tesla’s solar roof production volumes and its stock price hadn’t undergone the required preapproval by Tesla’s lawyers. The communications, which haven’t been previously reported, spotlight the running tension between the nation’s top corporate regulator and Mr. Musk, who publicly mocked the SEC even after settling fraud claims with the agency. The SEC told Tesla in May 2020 that the company had failed ‘to enforce these procedures and controls despite repeated violations by Mr. Musk.’ The letter, signed by Steven Buchholz, a senior SEC official in its San Francisco office, added: ‘Tesla has abdicated the duties required of it by the court’s order.’\"\n</blockquote>\n<p>Whether installation speed has picked up meaningfully over the past few months is unclear thanks in no small part to Tesla's inconsistency with regard to reporting on the subject. Thus, while Tesla's Q1 investor letter boasted that Solar Roof installations \"grew 9x compared to the same period last year,\" it neglected to provide an exact number of MW deployed. The Q2 update offered still less clarity, failing to mention even the growth rate other than to say that deployments \"grew substantially\" on a sequential and year-over-year basis.</p>\n<p><b>Investor's Eye View</b></p>\n<p>Whatever way you slice it, Tesla’s seemingly endless struggle to launch a viable solar roof product at scale is problematic for a company that is valued based on a highly optimistic growth narrative. Tesla's market capitalization, which currently stands in excess of $670 billion, is nearly five times greater than that of Volkswagen AG (OTCPK:VWAGY), the world's largest automaker. That is in spite of the fact that Tesla currently has barely 5% of Volkswagen's annual automotive production capacity. In other words, Tesla is currently priced as if it will not only surpass the likes of Volkswagen in terms of production and sales volume, but will radically exceed them.</p>\n<p>While irrational exuberance about an EV-dominated future can explain some of Tesla's eye-watering share price, it is not the only factor. Tesla's valuation is also the result of the company's efforts to position itself as \"more than a car company.\" Solar has always been a core component of this narrative, yet it has failed to live up to the hype. Deployments remain far below the highs set half a decade ago, even as&nbsp;customer satisfaction&nbsp;has continued to fall.</p>\n<p>Moreover, the fundamental economics of Tesla's solar operations have always been shaky at best. Indeed, even as Tesla's automotive operations have inched toward breakeven, the&nbsp;margins for its solar business remain painfully negative. That is hardly a glowing endorsement of a business unit that is supposed to add to Tesla's value proposition, not detract from it.</p>\n<p>In sum, Tesla's valuation is the product of high expectations and belief in the company's ability to expand its offerings far beyond the conventional automotive realm. Based on the performance of its solar energy business to date, it would seem prudent to revise some of those expectations downward.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inside The Deterioration Of Tesla's Solar Business</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInside The Deterioration Of Tesla's Solar Business\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-24 11:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4451383-inside-the-deterioration-of-teslas-solar-business><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nTesla's $670 billion market cap is based in part on the belief that it is \"more than a car company\"; Tesla's solar energy business has fed this narrative.\nWhile treated like a value-add by ...</p>\n\n<a href=\"https://seekingalpha.com/article/4451383-inside-the-deterioration-of-teslas-solar-business\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://seekingalpha.com/article/4451383-inside-the-deterioration-of-teslas-solar-business","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1187997976","content_text":"Summary\n\nTesla's $670 billion market cap is based in part on the belief that it is \"more than a car company\"; Tesla's solar energy business has fed this narrative.\nWhile treated like a value-add by Tesla's boosters, its solar unit has in practice been a costly millstone; margins remain deeply negative.\nTesla's solar deployments have fallen far from highs set years ago, with little prospect of a reversal.\nHopes that Tesla's Solar Roof could reinvigorate deployment rates have faded amid multi-year delays and persistent installation bottlenecks.\nAs Tesla's solar business fades, it may threaten the company's broader growth narrative, as well as its vaunted share price.\n\nRoschetzkyIstockPhoto/iStock Editorial via Getty Images\nAs any of my longtime readers can undoubtedly attest, I have been tracking Tesla Inc. (NASDAQ:TSLA) for a while. I have covered numerous subjects related to the electric vehicle (“EV”) company over the years, but I have returned often to one in particular: Tesla’s solar energy business.\nIt has been a while since I lasttook a look under the hoodof Tesla’s solar division. With the first two quarters of 2021 in the rearview mirror, it feels like now is a good time to revisit the long-struggling business unit.\nMuch has changed for Tesla Solar in 2021, little of it for the good. Let’s discuss why this is the case.\nSolar Deployments In H1 2021: Still In A Long-Term Downtrend\nAs I have discussed at length on numerous occasions over the years, Tesla Solar has been in material multi-year decline from a deployments perspective. Thus, when Tesla reported Q1 2021 earnings, I naturally looked to the solar deployment numbers to see if the negative pattern had continued. As it turned out, Tesla had managed to achieve a major sequential jump in deployments, a fact the company was quick tocrow about in its Q1 investor letter:\n\n “Solar Retrofit and Solar Roof Solar deployments reached 92 MW in Q1, our strongest quarter in 2.5 years. Solar Roof deployments grew 9x compared to the same period last year.”\n\nTesla reported solar deployments to the tune of 92 megawatts (“MW”) in Q1, the most it had managed in years. Under the circumstances, Tesla can hardly be blamed for having wanted to highlight such a marked improvement in chart form:\nSource: Tesla Inc.\nThe chart above, which was included in the Q1 investor letter, certainly looks like it could be a sign of a turnaround in the making. However, its relatively limited timescale also limits its usefulness to investors and analysts interested in understanding the long-term performance and trajectory of Tesla's solar business. Charting the full history of Tesla's quarterly solar deployments through Q1 2021 offers a rather different perspective:\nSource: Author; Tesla Inc.\nI hardly have to remind investors that one quarter of growth does not a pattern make. If Tesla could sustain that growth into Q2, then one might be able to talk legitimately about a turnaround. As it turned out, Tesladeployed just 85 MW in Q2, a more than7.5% sequential drop:\nSource: TeslaCharts; Tesla Inc.\nTesla's solar deployments were not just lower in Q2 than in Q1, however. At 85MW, Tesla actually managed one 1MW less than it did in Q4 2020, despite seasonal impacts traditionally weakening year-end solar deployment rates. That would seem to put paid to any notion that Tesla's solar operations have been making a significant or sustainable turnaround.\nDeployments may have climbed significantly from their nadir in the first half of last year, but they remain a pale shadow of what Tesla was managing five years ago. They are also radically lower than what Tesla itself hadprojected in 2016when it was in the process of acquiring SolarCity:\nSource: @C_S_Skeptic; GLJ Research; Tesla Inc.\nIn 2016, Tesla was predicting solar deployments in excess of 500MW per quarter starting in 2017. We are now mid-way through 2021 and quarterly solar deployment levels stand at less than 20% of that figure.\nProduct Progress: Solar Roof Still Not Ready For Prime Time\nUnveiled with great fanfare in October 2016,the Solar Roof was touted from the start as the future of solar energy technology. At the time, CEO Elon Musk was insistent that the Solar Roof was not merely a concept in development, but was actually a fully functional technology ready to enter full-scale production. Musk told his rapt audience that the acquisition of SolarCity would facilitate the rapid rollout of the Solar Roof, providing one of the first public justifications for the merger between Tesla and the virtually insolvent solar installer that had been founded by two of Musk's cousins, and of which Musk was then chairman of the board of directors.\nSource: Tesla Inc.\nThe Solar Roof unveiling event may have helped smooth the way for the SolarCity tie-up, but it did so at the price of full transparency about the technology's readiness. Musk's claim about the Solar Roof's immediate viability was proven false in short order, as it quickly became apparent that the Solar Roof was still very much a concept in development, and with little near-term prospect of commercialization. Even then, few could have guessed how long that design and development process would take.\nA review of the progress to date on the long-promised but oft-delayed Solar Roof reveals a business reality far different from what has long been promised by Tesla’s solar cheerleaders. In the years since it was unveiled, the Solar Roof has gone through multipleredesigns and rebrands, even as Musk has repeatedly assured investors and the public that full-scale commercial production was imminent. In March 2019, he declared that 2019 would be \"the Year of the Solar Roof.\" In July of the same year, Musk tweeted that Solar Roof production wasaccelerating toward 1,000 units roofs per week:\nSource: Elon Musk; Twitter\nThis claim raised plenty of eyebrows in the investment community. Their skepticism proved well deserved as it soon became apparent that the actual Solar Roof production and installation rates were far lower. Even Electrek, a website well known for its consistently bullish Tesla commentary, felt compelled to call Musk out on his claim. According to Electrek, Musk's tweet was \"a bit of an exaggeration\" and that the actual production rate at the time was closer to 500 Solar Roofs per week. However, even that reduced projection appears to overstate the level of steady-state production and installation by a significant margin.\nThe Solar Roof has seen its fortunes improve little in 2021 thus far. According to renewable energy industry journalist Eric Wesoff, Tesla had yet to install 1,000 Solar Roofs total as recently as this April. This pessimistic view was further reinforced last month when the Wall Street Journal reported that the Securities and Exchange Commission had already confronted Tesla over Musk's dubious prior Solar Roof claims:\n\n “In correspondence sent to Tesla in 2019 and 2020, the SEC said tweets Mr. Musk wrote about Tesla’s solar roof production volumes and its stock price hadn’t undergone the required preapproval by Tesla’s lawyers. The communications, which haven’t been previously reported, spotlight the running tension between the nation’s top corporate regulator and Mr. Musk, who publicly mocked the SEC even after settling fraud claims with the agency. The SEC told Tesla in May 2020 that the company had failed ‘to enforce these procedures and controls despite repeated violations by Mr. Musk.’ The letter, signed by Steven Buchholz, a senior SEC official in its San Francisco office, added: ‘Tesla has abdicated the duties required of it by the court’s order.’\"\n\nWhether installation speed has picked up meaningfully over the past few months is unclear thanks in no small part to Tesla's inconsistency with regard to reporting on the subject. Thus, while Tesla's Q1 investor letter boasted that Solar Roof installations \"grew 9x compared to the same period last year,\" it neglected to provide an exact number of MW deployed. The Q2 update offered still less clarity, failing to mention even the growth rate other than to say that deployments \"grew substantially\" on a sequential and year-over-year basis.\nInvestor's Eye View\nWhatever way you slice it, Tesla’s seemingly endless struggle to launch a viable solar roof product at scale is problematic for a company that is valued based on a highly optimistic growth narrative. Tesla's market capitalization, which currently stands in excess of $670 billion, is nearly five times greater than that of Volkswagen AG (OTCPK:VWAGY), the world's largest automaker. That is in spite of the fact that Tesla currently has barely 5% of Volkswagen's annual automotive production capacity. In other words, Tesla is currently priced as if it will not only surpass the likes of Volkswagen in terms of production and sales volume, but will radically exceed them.\nWhile irrational exuberance about an EV-dominated future can explain some of Tesla's eye-watering share price, it is not the only factor. Tesla's valuation is also the result of the company's efforts to position itself as \"more than a car company.\" Solar has always been a core component of this narrative, yet it has failed to live up to the hype. Deployments remain far below the highs set half a decade ago, even as customer satisfaction has continued to fall.\nMoreover, the fundamental economics of Tesla's solar operations have always been shaky at best. Indeed, even as Tesla's automotive operations have inched toward breakeven, the margins for its solar business remain painfully negative. That is hardly a glowing endorsement of a business unit that is supposed to add to Tesla's value proposition, not detract from it.\nIn sum, Tesla's valuation is the product of high expectations and belief in the company's ability to expand its offerings far beyond the conventional automotive realm. Based on the performance of its solar energy business to date, it would seem prudent to revise some of those expectations downward.","news_type":1},"isVote":1,"tweetType":1,"viewCount":60,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836991634,"gmtCreate":1629444361128,"gmtModify":1629444586249,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577554594597387","idStr":"3577554594597387"},"themes":[],"htmlText":"Ummmm the article right before this is the exact opposite headlined “something has got to give” in the stock market, warning of a crash........&nbsp;","listText":"Ummmm the article right before this is the exact opposite headlined “something has got to give” in the stock market, warning of a crash........&nbsp;","text":"Ummmm the article right before this is the exact opposite headlined “something has got to give” in the stock market, warning of a crash........","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/836991634","repostId":"2160848793","repostType":4,"isVote":1,"tweetType":1,"viewCount":159,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890203730,"gmtCreate":1628118313920,"gmtModify":1628128189095,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577554594597387","idStr":"3577554594597387"},"themes":[],"htmlText":"Ummmm so I brought puts on CCL because Delta was spreading—— and then it rallied up 16% in the 2days after&nbsp;","listText":"Ummmm so I brought puts on CCL because Delta was spreading—— and then it rallied up 16% in the 2days after&nbsp;","text":"Ummmm so I brought puts on CCL because Delta was spreading—— and then it rallied up 16% in the 2days after","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/890203730","repostId":"2156106357","repostType":4,"isVote":1,"tweetType":1,"viewCount":264,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804572295,"gmtCreate":1627968506217,"gmtModify":1627969502204,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577554594597387","idStr":"3577554594597387"},"themes":[],"htmlText":"Motley Fool I have learnt my lesson, I will be buying puts on these&nbsp;","listText":"Motley Fool I have learnt my lesson, I will be buying puts on these&nbsp;","text":"Motley Fool I have learnt my lesson, I will be buying puts on these","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804572295","repostId":"2156116066","repostType":4,"isVote":1,"tweetType":1,"viewCount":168,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":142108949,"gmtCreate":1626135006681,"gmtModify":1626141001447,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577554594597387","idStr":"3577554594597387"},"themes":[],"htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/142108949","repostId":"1128533375","repostType":4,"repost":{"id":"1128533375","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626098621,"share":"https://www.laohu8.com/m/news/1128533375?lang=&edition=full","pubTime":"2021-07-12 22:03","market":"us","language":"en","title":"SPI Energy stock jumps 17% on launching next generation electric pickup truck EF1-T","url":"https://stock-news.laohu8.com/highlight/detail?id=1128533375","media":"Tiger Newspress","summary":"SPI Energy stock jumps 17% on announcing the launch of next-generation electric pickup truck, EF1-T ","content":"<ul>\n <li>SPI Energy stock jumps 17% on&nbsp;announcing&nbsp;the launch of next-generation electric pickup truck, EF1-T by&nbsp;its wholly owned EdisonFuture, Inc. and PhoenixMotor Inc. subsidiary.</li>\n <li>The EF1-T standard model comes equipped with total power of 350 kilowatts, or 470 horsepower, while EdisonFuture's top of the line \"Super\" model offers 600kW, or 816HP.</li>\n <li>\"Our vision for EdisionFuture and Phoenix Motorcars is to be leaders in sustainable transportation with focus on energy efficiency and innovative design,\" stated Mr. Xiaofeng Peng, Chairman &amp; Chief Executive Officer of SPI Energy. \"We have already filed multiple design and technology patents in the US related to the EF1-T and look forward to introducing this game-changing vehicle to the market in the coming months.\"</li>\n <li>Approximately 2.9M pickup trucks were sold in the US in 2020, +20% of the entire US auto market.</li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/0bd67d49b5a0a872ac8d4bf5ef7788a7\" tg-width=\"1297\" tg-height=\"592\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SPI Energy stock jumps 17% on launching next generation electric pickup truck EF1-T</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSPI Energy stock jumps 17% on launching next generation electric pickup truck EF1-T\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-12 22:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>SPI Energy stock jumps 17% on&nbsp;announcing&nbsp;the launch of next-generation electric pickup truck, EF1-T by&nbsp;its wholly owned EdisonFuture, Inc. and PhoenixMotor Inc. subsidiary.</li>\n <li>The EF1-T standard model comes equipped with total power of 350 kilowatts, or 470 horsepower, while EdisonFuture's top of the line \"Super\" model offers 600kW, or 816HP.</li>\n <li>\"Our vision for EdisionFuture and Phoenix Motorcars is to be leaders in sustainable transportation with focus on energy efficiency and innovative design,\" stated Mr. Xiaofeng Peng, Chairman &amp; Chief Executive Officer of SPI Energy. \"We have already filed multiple design and technology patents in the US related to the EF1-T and look forward to introducing this game-changing vehicle to the market in the coming months.\"</li>\n <li>Approximately 2.9M pickup trucks were sold in the US in 2020, +20% of the entire US auto market.</li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/0bd67d49b5a0a872ac8d4bf5ef7788a7\" tg-width=\"1297\" tg-height=\"592\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPI":"阳光动力"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128533375","content_text":"SPI Energy stock jumps 17% on announcing the launch of next-generation electric pickup truck, EF1-T by its wholly owned EdisonFuture, Inc. and PhoenixMotor Inc. subsidiary.\nThe EF1-T standard model comes equipped with total power of 350 kilowatts, or 470 horsepower, while EdisonFuture's top of the line \"Super\" model offers 600kW, or 816HP.\n\"Our vision for EdisionFuture and Phoenix Motorcars is to be leaders in sustainable transportation with focus on energy efficiency and innovative design,\" stated Mr. Xiaofeng Peng, Chairman & Chief Executive Officer of SPI Energy. \"We have already filed multiple design and technology patents in the US related to the EF1-T and look forward to introducing this game-changing vehicle to the market in the coming months.\"\nApproximately 2.9M pickup trucks were sold in the US in 2020, +20% of the entire US auto market.","news_type":1},"isVote":1,"tweetType":1,"viewCount":14,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":169634932,"gmtCreate":1623832170126,"gmtModify":1623832217121,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577554594597387","idStr":"3577554594597387"},"themes":[],"htmlText":"Hurry up I have call options expiring","listText":"Hurry up I have call options expiring","text":"Hurry up I have call options expiring","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/169634932","repostId":"2143075116","repostType":2,"isVote":1,"tweetType":1,"viewCount":129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":694747411,"gmtCreate":1642141319751,"gmtModify":1642141813792,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577554594597387","authorIdStr":"3577554594597387"},"themes":[],"htmlText":"Love the headline&nbsp;*NASDAQ -2.51% 😂","listText":"Love the headline&nbsp;*NASDAQ -2.51% 😂","text":"Love the headline *NASDAQ -2.51% 😂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/694747411","repostId":"1138592368","repostType":4,"repost":{"id":"1138592368","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641997842,"share":"https://www.laohu8.com/m/news/1138592368?lang=&edition=full","pubTime":"2022-01-12 22:30","market":"us","language":"en","title":"Stocks rise as Wall Street shakes off red hot inflation report","url":"https://stock-news.laohu8.com/highlight/detail?id=1138592368","media":"Tiger Newspress","summary":"Stocks rose Wednesday as investors eyed a new report on inflation, which showed another decades-high","content":"<html><head></head><body><p>Stocks rose Wednesday as investors eyed a new report on inflation, which showed another decades-high rate of price increases across the recovering economy. Still, this came a day following remarks from Federal Reserve Chair Jerome Powell reasserting that the central bank would step in as needed to rein in rising prices.</p><p>The Bureau of Labor Statistics&#39; December Consumer Price Index (CPI)showed prices rose at a 7.0% year-over-year rate at the end of 2021, marking the fastest increase since 1982. This matched consensus estimates, based on Bloomberg data, and accelerated from November&#39;s already elevated 6.8% increase. On a month-over-month basis, consumer prices rose 0.5%, or slightly more than the 0.4% rise expected, to mark an eighteenth consecutive month of prices increases.</p><p>Excluding food and energy prices, the so-called core measure of consumer prices rose 5.5% in December over last year, coming in at the fastest rate since 1991.</p><p>Wednesday&#39;s market moves came following a rebound rally on Tuesday, with markets at least temporarily finding relief in assurances from Federal Reserve Chair Jerome Powell that the central bank would step in as necessary to ease rising prices. InPowell&#39;s renomination hearing before the Senate Banking Committee, the central bank leader reiterated that the Fed would use its policy tools to bring down inflation.</p><p>“If we see inflation persisting at high levels, longer than expected, if we have to raise interest rates more over time, then we will,” Powell said during the hearing.</p><p>The central bankpreviously telegraphed it was eyeing three interest rate hikesthis year to bring benchmark rates up from their current near-zero levels. However, some topWall Street firms have predictedthe Fed will raise rates four times given the current inflationary backdrop.</p><p>But though Powell doubled down on the Fed&#39;s goal of curbing inflation and using interest rate hikes as a tool to achieve this, he revealed little further about the Fed&#39;s plan to begin shrinking its nearly $9 trillion balance sheet. The Fed&#39;s December meeting minutes last week suggested central bank officials were beginning to discuss drawing down the Fed&#39;s balance sheet after nearly two years of asset purchases to help support markets during the pandemic. Powell did reiterate in his hearing he expected the balance sheet runoff process would begin this year.</p><p>&#34;I think the biggest comment on most investors&#39; minds that we talk to around the world would be a &#39;policy mistake&#39; that the Fed might be too aggressive,&#34; Brian Belski, BMO Capital Markets chief investment strategist,told Yahoo Finance Live on Tuesday.&#34;Mr. Powell basically came out today and said this is going to be a process ... with respect to how long this is going to take, and I think that&#39;s what&#39;s calming investors.&#34;</p><p>Though prospects of higher borrowing costs and tighter financial conditions have stirred up volatility in U.S. equities and tech stocks especially in recent sessions, Tuesday&#39;s session saw a reversal, with the tech-heavy Nasdaq Composite sharply outperforming.</p><p>&#34;The issue with tech, I would argue, is not so much one of a little extra duration exposure because growth is further away, but it&#39;s simply one of valuation,&#34; Simeon Hyman, ProShares Global Investment Strategist,told Yahoo Finance Live on Tuesday.&#34;And indeed those top-heavy, largest-cap tech stocks perhaps just were a little bit expensive going into the end of last year and the beginning of 2022. But don&#39;t completely rule out good growth stories because that is the biggest defense against inflation. It is the growth of earnings and dividends.&#34;</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks rise as Wall Street shakes off red hot inflation report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks rise as Wall Street shakes off red hot inflation report\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-12 22:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Stocks rose Wednesday as investors eyed a new report on inflation, which showed another decades-high rate of price increases across the recovering economy. Still, this came a day following remarks from Federal Reserve Chair Jerome Powell reasserting that the central bank would step in as needed to rein in rising prices.</p><p>The Bureau of Labor Statistics&#39; December Consumer Price Index (CPI)showed prices rose at a 7.0% year-over-year rate at the end of 2021, marking the fastest increase since 1982. This matched consensus estimates, based on Bloomberg data, and accelerated from November&#39;s already elevated 6.8% increase. On a month-over-month basis, consumer prices rose 0.5%, or slightly more than the 0.4% rise expected, to mark an eighteenth consecutive month of prices increases.</p><p>Excluding food and energy prices, the so-called core measure of consumer prices rose 5.5% in December over last year, coming in at the fastest rate since 1991.</p><p>Wednesday&#39;s market moves came following a rebound rally on Tuesday, with markets at least temporarily finding relief in assurances from Federal Reserve Chair Jerome Powell that the central bank would step in as necessary to ease rising prices. InPowell&#39;s renomination hearing before the Senate Banking Committee, the central bank leader reiterated that the Fed would use its policy tools to bring down inflation.</p><p>“If we see inflation persisting at high levels, longer than expected, if we have to raise interest rates more over time, then we will,” Powell said during the hearing.</p><p>The central bankpreviously telegraphed it was eyeing three interest rate hikesthis year to bring benchmark rates up from their current near-zero levels. However, some topWall Street firms have predictedthe Fed will raise rates four times given the current inflationary backdrop.</p><p>But though Powell doubled down on the Fed&#39;s goal of curbing inflation and using interest rate hikes as a tool to achieve this, he revealed little further about the Fed&#39;s plan to begin shrinking its nearly $9 trillion balance sheet. The Fed&#39;s December meeting minutes last week suggested central bank officials were beginning to discuss drawing down the Fed&#39;s balance sheet after nearly two years of asset purchases to help support markets during the pandemic. Powell did reiterate in his hearing he expected the balance sheet runoff process would begin this year.</p><p>&#34;I think the biggest comment on most investors&#39; minds that we talk to around the world would be a &#39;policy mistake&#39; that the Fed might be too aggressive,&#34; Brian Belski, BMO Capital Markets chief investment strategist,told Yahoo Finance Live on Tuesday.&#34;Mr. Powell basically came out today and said this is going to be a process ... with respect to how long this is going to take, and I think that&#39;s what&#39;s calming investors.&#34;</p><p>Though prospects of higher borrowing costs and tighter financial conditions have stirred up volatility in U.S. equities and tech stocks especially in recent sessions, Tuesday&#39;s session saw a reversal, with the tech-heavy Nasdaq Composite sharply outperforming.</p><p>&#34;The issue with tech, I would argue, is not so much one of a little extra duration exposure because growth is further away, but it&#39;s simply one of valuation,&#34; Simeon Hyman, ProShares Global Investment Strategist,told Yahoo Finance Live on Tuesday.&#34;And indeed those top-heavy, largest-cap tech stocks perhaps just were a little bit expensive going into the end of last year and the beginning of 2022. But don&#39;t completely rule out good growth stories because that is the biggest defense against inflation. It is the growth of earnings and dividends.&#34;</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138592368","content_text":"Stocks rose Wednesday as investors eyed a new report on inflation, which showed another decades-high rate of price increases across the recovering economy. Still, this came a day following remarks from Federal Reserve Chair Jerome Powell reasserting that the central bank would step in as needed to rein in rising prices.The Bureau of Labor Statistics' December Consumer Price Index (CPI)showed prices rose at a 7.0% year-over-year rate at the end of 2021, marking the fastest increase since 1982. This matched consensus estimates, based on Bloomberg data, and accelerated from November's already elevated 6.8% increase. On a month-over-month basis, consumer prices rose 0.5%, or slightly more than the 0.4% rise expected, to mark an eighteenth consecutive month of prices increases.Excluding food and energy prices, the so-called core measure of consumer prices rose 5.5% in December over last year, coming in at the fastest rate since 1991.Wednesday's market moves came following a rebound rally on Tuesday, with markets at least temporarily finding relief in assurances from Federal Reserve Chair Jerome Powell that the central bank would step in as necessary to ease rising prices. InPowell's renomination hearing before the Senate Banking Committee, the central bank leader reiterated that the Fed would use its policy tools to bring down inflation.“If we see inflation persisting at high levels, longer than expected, if we have to raise interest rates more over time, then we will,” Powell said during the hearing.The central bankpreviously telegraphed it was eyeing three interest rate hikesthis year to bring benchmark rates up from their current near-zero levels. However, some topWall Street firms have predictedthe Fed will raise rates four times given the current inflationary backdrop.But though Powell doubled down on the Fed's goal of curbing inflation and using interest rate hikes as a tool to achieve this, he revealed little further about the Fed's plan to begin shrinking its nearly $9 trillion balance sheet. The Fed's December meeting minutes last week suggested central bank officials were beginning to discuss drawing down the Fed's balance sheet after nearly two years of asset purchases to help support markets during the pandemic. Powell did reiterate in his hearing he expected the balance sheet runoff process would begin this year.\"I think the biggest comment on most investors' minds that we talk to around the world would be a 'policy mistake' that the Fed might be too aggressive,\" Brian Belski, BMO Capital Markets chief investment strategist,told Yahoo Finance Live on Tuesday.\"Mr. Powell basically came out today and said this is going to be a process ... with respect to how long this is going to take, and I think that's what's calming investors.\"Though prospects of higher borrowing costs and tighter financial conditions have stirred up volatility in U.S. equities and tech stocks especially in recent sessions, Tuesday's session saw a reversal, with the tech-heavy Nasdaq Composite sharply outperforming.\"The issue with tech, I would argue, is not so much one of a little extra duration exposure because growth is further away, but it's simply one of valuation,\" Simeon Hyman, ProShares Global Investment Strategist,told Yahoo Finance Live on Tuesday.\"And indeed those top-heavy, largest-cap tech stocks perhaps just were a little bit expensive going into the end of last year and the beginning of 2022. But don't completely rule out good growth stories because that is the biggest defense against inflation. It is the growth of earnings and dividends.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":528,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":836991634,"gmtCreate":1629444361128,"gmtModify":1629444586249,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577554594597387","authorIdStr":"3577554594597387"},"themes":[],"htmlText":"Ummmm the article right before this is the exact opposite headlined “something has got to give” in the stock market, warning of a crash........&nbsp;","listText":"Ummmm the article right before this is the exact opposite headlined “something has got to give” in the stock market, warning of a crash........&nbsp;","text":"Ummmm the article right before this is the exact opposite headlined “something has got to give” in the stock market, warning of a crash........","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/836991634","repostId":"2160848793","repostType":4,"isVote":1,"tweetType":1,"viewCount":159,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812754922,"gmtCreate":1630626922066,"gmtModify":1630634981855,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577554594597387","authorIdStr":"3577554594597387"},"themes":[],"htmlText":"Damn wish I had puts on this!&nbsp;","listText":"Damn wish I had puts on this!&nbsp;","text":"Damn wish I had puts on this!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/812754922","repostId":"1186835624","repostType":2,"repost":{"id":"1186835624","pubTimestamp":1630625981,"share":"https://www.laohu8.com/m/news/1186835624?lang=&edition=full","pubTime":"2021-09-03 07:39","market":"us","language":"en","title":"Forte Biosciences' shares fall 82% after scrapping development of FB-401 treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1186835624","media":"seekingalpha","summary":"Forte Biosciences announces that it will not continue to advance the development of its atopic derma","content":"<p>Forte Biosciences&nbsp;announces that it&nbsp;will not continue to advance the development of its atopic dermatitis treatment FB-401 following mid-stage trial results.</p>\n<p>Shares slide nearly&nbsp;82%&nbsp;post market.</p>\n<p><img src=\"https://static.tigerbbs.com/ba305cccf4317784780adcba0d37993e\" tg-width=\"1020\" tg-height=\"522\" width=\"100%\" height=\"auto\"></p>\n<p>In the phase 2 study, the drug failed to meet statistical significance for the primary endpoint of EASI-50 (the proportion of patients with at least a 50% improvement in atopic dermatitis disease severity as measure by EASI), the company said.</p>\n<p>\"The topline data is disappointing and we will continue to analyze the data; however, given this readout we will not continue to advance FB-401,\" CEO Paul Wagner said.</p>\n<p>Forte Biosciences previously reported that it had cash and cash equivalents of $50.8M as of June 30, 2021.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forte Biosciences' shares fall 82% after scrapping development of FB-401 treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForte Biosciences' shares fall 82% after scrapping development of FB-401 treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-03 07:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3736993-forte-biosciences-shares-fall-12-after-scrapping-development-of-fb-401-treatment><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Forte Biosciences announces that it will not continue to advance the development of its atopic dermatitis treatment FB-401 following mid-stage trial results.\nShares slide nearly 82% post market.\n\nIn ...</p>\n\n<a href=\"https://seekingalpha.com/news/3736993-forte-biosciences-shares-fall-12-after-scrapping-development-of-fb-401-treatment\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FBRX":"Forte BioSciences Inc"},"source_url":"https://seekingalpha.com/news/3736993-forte-biosciences-shares-fall-12-after-scrapping-development-of-fb-401-treatment","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1186835624","content_text":"Forte Biosciences announces that it will not continue to advance the development of its atopic dermatitis treatment FB-401 following mid-stage trial results.\nShares slide nearly 82% post market.\n\nIn the phase 2 study, the drug failed to meet statistical significance for the primary endpoint of EASI-50 (the proportion of patients with at least a 50% improvement in atopic dermatitis disease severity as measure by EASI), the company said.\n\"The topline data is disappointing and we will continue to analyze the data; however, given this readout we will not continue to advance FB-401,\" CEO Paul Wagner said.\nForte Biosciences previously reported that it had cash and cash equivalents of $50.8M as of June 30, 2021.","news_type":1},"isVote":1,"tweetType":1,"viewCount":269,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":605928154,"gmtCreate":1639103338852,"gmtModify":1639103436390,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577554594597387","authorIdStr":"3577554594597387"},"themes":[],"htmlText":"“Pops” it’s half a percent up AH 😂😂","listText":"“Pops” it’s half a percent up AH 😂😂","text":"“Pops” it’s half a percent up AH 😂😂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605928154","repostId":"1186120067","repostType":4,"repost":{"id":"1186120067","pubTimestamp":1639102922,"share":"https://www.laohu8.com/m/news/1186120067?lang=&edition=full","pubTime":"2021-12-10 10:22","market":"us","language":"en","title":"OCGN Stock Pops on Key FDA News. Here’s What to Know.","url":"https://stock-news.laohu8.com/highlight/detail?id=1186120067","media":"InvestorPlace","summary":"Biopharmaceutical company Ocugen(NASDAQ:OCGN) announced today that the U.S. Food and Drug Administra","content":"<p>Biopharmaceutical company&nbsp;<b>Ocugen</b>(NASDAQ:<b><u>OCGN</u></b>) announced today that the U.S. Food and Drug Administration (FDA) approved the company’s Investigational New Drug (IND) application for a human clinical trial of OCU400. OCU400 is a gene-therapy candidate targeting several degenerative eye diseases that severely impair vision. Despite the news, OCGN stock is down 6.3% today as investors seem reluctant to buy into the struggling med-tech company.</p>\n<p>Shankar Musunuri, chief executive and co-founder of Ocugen, commented on&nbsp;the significance of this recent development.</p>\n<blockquote>\n <i>“We are delighted to advance OCU400 into clinical trials, which exemplifies our goal of offering new options to people with genetic diseases where none currently exist. … We’re collaborating with leading centers in eye care and have been vital partners to getting our trial launched and receive patients. With this final decision by the FDA, we are embarking on a new pathway of care through this innovative gene therapy.”</i>\n</blockquote>\n<p>The news comes as a welcome change of pace for the company. Ocugen is perhaps best known for its Covid-19 vaccine Covaxin, which largely lags behind the competition. On Nov. 30, the FDA&nbsp;issued a hold&nbsp;on an approval application for late-stage clinical testing of its vaccine.</p>\n<p>Ocugen represents just the North American side of the vaccine’s distribution. Meanwhile,&nbsp;<b>Bharat Biotech</b>, co-developer of the vaccine, has earned approval for use in 17 countries, including the company’s native India. This stands in stark contrast to Ocugen, who many investors believe is&nbsp;too little too late. Ocugen has come under fire for attempting to penetrate largely saturated Western markets as it pertains to vaccine options.</p>\n<p>Will this latest news shake things up for the struggling pharma company?</p>\n<p>OCU400: A Silver Lining for Struggling OCGN stock</p>\n<p>Arguably, OCU400 is Ocugen’s main prize-horse going forward. Anticipation surrounding the company’s breakthrough gene-therapy programs has taken OCGN stock to the moon and back in the past few years. However, that anticipation has largely died down. With many estimating it could be years before such a therapy hits the market, combined with seemingly constant roadblocks for its vaccine candidate, OCGN stock has been on a cold streak for quite a while. Therefore, this news should come as a breath of fresh air for OCGN investors.</p>\n<p>Preliminary estimates see OCU400 being a completely novel solution to a series of retinal degenerative diseases. This year, the European Medicines Agency (EMA) even granted OCU400 a broad medical designation&nbsp;for two different optical diseases.</p>\n<p>While investors currently seem hesitant, hope isn’t lost yet. Positive developments of this nature can create the positive momentum necessary to bring the stock back from the dead.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OCGN Stock Pops on Key FDA News. Here’s What to Know.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOCGN Stock Pops on Key FDA News. Here’s What to Know.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-10 10:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/ocgn-stock-pops-on-key-fda-news-heres-what-to-know/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biopharmaceutical company Ocugen(NASDAQ:OCGN) announced today that the U.S. Food and Drug Administration (FDA) approved the company’s Investigational New Drug (IND) application for a human clinical ...</p>\n\n<a href=\"https://investorplace.com/2021/12/ocgn-stock-pops-on-key-fda-news-heres-what-to-know/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://investorplace.com/2021/12/ocgn-stock-pops-on-key-fda-news-heres-what-to-know/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186120067","content_text":"Biopharmaceutical company Ocugen(NASDAQ:OCGN) announced today that the U.S. Food and Drug Administration (FDA) approved the company’s Investigational New Drug (IND) application for a human clinical trial of OCU400. OCU400 is a gene-therapy candidate targeting several degenerative eye diseases that severely impair vision. Despite the news, OCGN stock is down 6.3% today as investors seem reluctant to buy into the struggling med-tech company.\nShankar Musunuri, chief executive and co-founder of Ocugen, commented on the significance of this recent development.\n\n“We are delighted to advance OCU400 into clinical trials, which exemplifies our goal of offering new options to people with genetic diseases where none currently exist. … We’re collaborating with leading centers in eye care and have been vital partners to getting our trial launched and receive patients. With this final decision by the FDA, we are embarking on a new pathway of care through this innovative gene therapy.”\n\nThe news comes as a welcome change of pace for the company. Ocugen is perhaps best known for its Covid-19 vaccine Covaxin, which largely lags behind the competition. On Nov. 30, the FDA issued a hold on an approval application for late-stage clinical testing of its vaccine.\nOcugen represents just the North American side of the vaccine’s distribution. Meanwhile, Bharat Biotech, co-developer of the vaccine, has earned approval for use in 17 countries, including the company’s native India. This stands in stark contrast to Ocugen, who many investors believe is too little too late. Ocugen has come under fire for attempting to penetrate largely saturated Western markets as it pertains to vaccine options.\nWill this latest news shake things up for the struggling pharma company?\nOCU400: A Silver Lining for Struggling OCGN stock\nArguably, OCU400 is Ocugen’s main prize-horse going forward. Anticipation surrounding the company’s breakthrough gene-therapy programs has taken OCGN stock to the moon and back in the past few years. However, that anticipation has largely died down. With many estimating it could be years before such a therapy hits the market, combined with seemingly constant roadblocks for its vaccine candidate, OCGN stock has been on a cold streak for quite a while. Therefore, this news should come as a breath of fresh air for OCGN investors.\nPreliminary estimates see OCU400 being a completely novel solution to a series of retinal degenerative diseases. This year, the European Medicines Agency (EMA) even granted OCU400 a broad medical designation for two different optical diseases.\nWhile investors currently seem hesitant, hope isn’t lost yet. Positive developments of this nature can create the positive momentum necessary to bring the stock back from the dead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":366,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":804572295,"gmtCreate":1627968506217,"gmtModify":1627969502204,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577554594597387","authorIdStr":"3577554594597387"},"themes":[],"htmlText":"Motley Fool I have learnt my lesson, I will be buying puts on these&nbsp;","listText":"Motley Fool I have learnt my lesson, I will be buying puts on these&nbsp;","text":"Motley Fool I have learnt my lesson, I will be buying puts on these","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804572295","repostId":"2156116066","repostType":4,"isVote":1,"tweetType":1,"viewCount":168,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":142108949,"gmtCreate":1626135006681,"gmtModify":1626141001447,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577554594597387","authorIdStr":"3577554594597387"},"themes":[],"htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/142108949","repostId":"1128533375","repostType":4,"repost":{"id":"1128533375","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626098621,"share":"https://www.laohu8.com/m/news/1128533375?lang=&edition=full","pubTime":"2021-07-12 22:03","market":"us","language":"en","title":"SPI Energy stock jumps 17% on launching next generation electric pickup truck EF1-T","url":"https://stock-news.laohu8.com/highlight/detail?id=1128533375","media":"Tiger Newspress","summary":"SPI Energy stock jumps 17% on announcing the launch of next-generation electric pickup truck, EF1-T ","content":"<ul>\n <li>SPI Energy stock jumps 17% on&nbsp;announcing&nbsp;the launch of next-generation electric pickup truck, EF1-T by&nbsp;its wholly owned EdisonFuture, Inc. and PhoenixMotor Inc. subsidiary.</li>\n <li>The EF1-T standard model comes equipped with total power of 350 kilowatts, or 470 horsepower, while EdisonFuture's top of the line \"Super\" model offers 600kW, or 816HP.</li>\n <li>\"Our vision for EdisionFuture and Phoenix Motorcars is to be leaders in sustainable transportation with focus on energy efficiency and innovative design,\" stated Mr. Xiaofeng Peng, Chairman &amp; Chief Executive Officer of SPI Energy. \"We have already filed multiple design and technology patents in the US related to the EF1-T and look forward to introducing this game-changing vehicle to the market in the coming months.\"</li>\n <li>Approximately 2.9M pickup trucks were sold in the US in 2020, +20% of the entire US auto market.</li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/0bd67d49b5a0a872ac8d4bf5ef7788a7\" tg-width=\"1297\" tg-height=\"592\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SPI Energy stock jumps 17% on launching next generation electric pickup truck EF1-T</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSPI Energy stock jumps 17% on launching next generation electric pickup truck EF1-T\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-12 22:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>SPI Energy stock jumps 17% on&nbsp;announcing&nbsp;the launch of next-generation electric pickup truck, EF1-T by&nbsp;its wholly owned EdisonFuture, Inc. and PhoenixMotor Inc. subsidiary.</li>\n <li>The EF1-T standard model comes equipped with total power of 350 kilowatts, or 470 horsepower, while EdisonFuture's top of the line \"Super\" model offers 600kW, or 816HP.</li>\n <li>\"Our vision for EdisionFuture and Phoenix Motorcars is to be leaders in sustainable transportation with focus on energy efficiency and innovative design,\" stated Mr. Xiaofeng Peng, Chairman &amp; Chief Executive Officer of SPI Energy. \"We have already filed multiple design and technology patents in the US related to the EF1-T and look forward to introducing this game-changing vehicle to the market in the coming months.\"</li>\n <li>Approximately 2.9M pickup trucks were sold in the US in 2020, +20% of the entire US auto market.</li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/0bd67d49b5a0a872ac8d4bf5ef7788a7\" tg-width=\"1297\" tg-height=\"592\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPI":"阳光动力"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128533375","content_text":"SPI Energy stock jumps 17% on announcing the launch of next-generation electric pickup truck, EF1-T by its wholly owned EdisonFuture, Inc. and PhoenixMotor Inc. subsidiary.\nThe EF1-T standard model comes equipped with total power of 350 kilowatts, or 470 horsepower, while EdisonFuture's top of the line \"Super\" model offers 600kW, or 816HP.\n\"Our vision for EdisionFuture and Phoenix Motorcars is to be leaders in sustainable transportation with focus on energy efficiency and innovative design,\" stated Mr. Xiaofeng Peng, Chairman & Chief Executive Officer of SPI Energy. \"We have already filed multiple design and technology patents in the US related to the EF1-T and look forward to introducing this game-changing vehicle to the market in the coming months.\"\nApproximately 2.9M pickup trucks were sold in the US in 2020, +20% of the entire US auto market.","news_type":1},"isVote":1,"tweetType":1,"viewCount":14,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":856229063,"gmtCreate":1635186675323,"gmtModify":1635209304258,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577554594597387","authorIdStr":"3577554594597387"},"themes":[],"htmlText":"Total FUD spam, HTZZ just ordered 100,000 Tesla’s and TSLA just blew past $1,000 per share! ♥️ TSLA","listText":"Total FUD spam, HTZZ just ordered 100,000 Tesla’s and TSLA just blew past $1,000 per share! ♥️ TSLA","text":"Total FUD spam, HTZZ just ordered 100,000 Tesla’s and TSLA just blew past $1,000 per share! ♥️ TSLA","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856229063","repostId":"2178427008","repostType":2,"isVote":1,"tweetType":1,"viewCount":690,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":816611661,"gmtCreate":1630495252853,"gmtModify":1630495602949,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577554594597387","authorIdStr":"3577554594597387"},"themes":[],"htmlText":"As a Millennial with no generational wealth and learning saving your pay check doesn’t get you anywhere this is so true! Get rich or die trying!&nbsp;","listText":"As a Millennial with no generational wealth and learning saving your pay check doesn’t get you anywhere this is so true! Get rich or die trying!&nbsp;","text":"As a Millennial with no generational wealth and learning saving your pay check doesn’t get you anywhere this is so true! Get rich or die trying!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/816611661","repostId":"1128788292","repostType":4,"isVote":1,"tweetType":1,"viewCount":514,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818476415,"gmtCreate":1630444487137,"gmtModify":1630462084987,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577554594597387","authorIdStr":"3577554594597387"},"themes":[],"htmlText":"So WFC tanked big time today after this promotion 😂","listText":"So WFC tanked big time today after this promotion 😂","text":"So WFC tanked big time today after this promotion 😂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/818476415","repostId":"1153871779","repostType":2,"isVote":1,"tweetType":1,"viewCount":323,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834887837,"gmtCreate":1629790224529,"gmtModify":1629795484786,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577554594597387","authorIdStr":"3577554594597387"},"themes":[],"htmlText":"Ooooo so looking like DR&nbsp;Michael Burry is right.... bring on the puts!&nbsp;","listText":"Ooooo so looking like DR&nbsp;Michael Burry is right.... bring on the puts!&nbsp;","text":"Ooooo so looking like DR Michael Burry is right.... bring on the puts!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/834887837","repostId":"1187997976","repostType":4,"repost":{"id":"1187997976","pubTimestamp":1629777349,"share":"https://www.laohu8.com/m/news/1187997976?lang=&edition=full","pubTime":"2021-08-24 11:55","market":"us","language":"en","title":"Inside The Deterioration Of Tesla's Solar Business","url":"https://stock-news.laohu8.com/highlight/detail?id=1187997976","media":"seekingalpha","summary":"Tesla's $670 billion market cap is based in part on the belief that it is \"more than a car company\"; Tesla's solar energy business has fed this narrative.While treated like a value-add by Tesla's boosters, its solar unit has in practice been a costly millstone; margins remain deeply negative.Tesla's solar deployments have fallen far from highs set years ago, with little prospect of a reversal.Hopes that Tesla's Solar Roof could reinvigorate deployment rates have faded amid multi-year delays and ","content":"<p>Summary</p>\n<ul>\n <li>Tesla's $670 billion market cap is based in part on the belief that it is \"more than a car company\"; Tesla's solar energy business has fed this narrative.</li>\n <li>While treated like a value-add by Tesla's boosters, its solar unit has in practice been a costly millstone; margins remain deeply negative.</li>\n <li>Tesla's solar deployments have fallen far from highs set years ago, with little prospect of a reversal.</li>\n <li>Hopes that Tesla's Solar Roof could reinvigorate deployment rates have faded amid multi-year delays and persistent installation bottlenecks.</li>\n <li>As Tesla's solar business fades, it may threaten the company's broader growth narrative, as well as its vaunted share price.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b04b99e933e100452f6e47f2c34a1460\" tg-width=\"768\" tg-height=\"512\" width=\"100%\" height=\"auto\"><span>RoschetzkyIstockPhoto/iStock Editorial via Getty Images</span></p>\n<p>As any of my longtime readers can undoubtedly attest, I have been tracking Tesla Inc. (NASDAQ:TSLA) for a while. I have covered numerous subjects related to the electric vehicle (“EV”) company over the years, but I have returned often to one in particular: Tesla’s solar energy business.</p>\n<p>It has been a while since I lasttook a look under the hoodof Tesla’s solar division. With the first two quarters of 2021 in the rearview mirror, it feels like now is a good time to revisit the long-struggling business unit.</p>\n<p>Much has changed for Tesla Solar in 2021, little of it for the good. Let’s discuss why this is the case.</p>\n<p>Solar Deployments In H1 2021: Still In A Long-Term Downtrend</p>\n<p>As I have&nbsp;discussed at length&nbsp;on&nbsp;numerous occasions&nbsp;over the years, Tesla Solar has been in material multi-year decline from a deployments perspective. Thus, when Tesla reported Q1 2021 earnings, I naturally looked to the solar deployment numbers to see if the negative pattern had continued. As it turned out, Tesla had managed to achieve a major sequential jump in deployments, a fact the company was quick tocrow about in its Q1 investor letter:</p>\n<blockquote>\n “Solar Retrofit and Solar Roof Solar deployments reached 92 MW in Q1, our strongest quarter in 2.5 years. Solar Roof deployments grew 9x compared to the same period last year.”\n</blockquote>\n<p>Tesla reported solar deployments to the tune of 92 megawatts (“MW”) in Q1, the most it had managed in years. Under the circumstances, Tesla can hardly be blamed for having wanted to highlight such a marked improvement in chart form:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7270ea980168a8e2976a38fd80b6b5c7\" tg-width=\"640\" tg-height=\"335\" width=\"100%\" height=\"auto\"><span>Source: Tesla Inc.</span></p>\n<p>The chart above, which was included in the Q1 investor letter, certainly looks like it could be a sign of a turnaround in the making. However, its relatively limited timescale also limits its usefulness to investors and analysts interested in understanding the long-term performance and trajectory of Tesla's solar business. Charting the full history of Tesla's quarterly solar deployments through Q1 2021 offers a rather different perspective:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/dab180dd817e9d4db21ed6ff4014e0d7\" tg-width=\"640\" tg-height=\"273\" width=\"100%\" height=\"auto\"><span>Source: Author; Tesla Inc.</span></p>\n<p>I hardly have to remind investors that one quarter of growth does not a pattern make. If Tesla could sustain that growth into Q2, then one might be able to talk legitimately about a turnaround. As it turned out, Tesladeployed just 85 MW in Q2, a more than7.5% sequential drop:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/43e076db4124ae5b339c1c78e6f33502\" tg-width=\"640\" tg-height=\"463\" width=\"100%\" height=\"auto\"><span>Source: TeslaCharts; Tesla Inc.</span></p>\n<p>Tesla's solar deployments were not just lower in Q2 than in Q1, however. At 85MW, Tesla actually managed one 1MW less than it did in Q4 2020, despite seasonal impacts traditionally weakening year-end solar deployment rates. That would seem to put paid to any notion that Tesla's solar operations have been making a significant or sustainable turnaround.</p>\n<p>Deployments may have climbed significantly from their nadir in the first half of last year, but they remain a pale shadow of what Tesla was managing five years ago. They are also radically lower than what Tesla itself hadprojected in 2016when it was in the process of acquiring SolarCity:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a0a31640e43eea612f1ca8aba8bea3ae\" tg-width=\"498\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Source: @C_S_Skeptic; GLJ Research; Tesla Inc.</span></p>\n<p>In 2016, Tesla was predicting solar deployments in excess of 500MW per quarter starting in 2017. We are now mid-way through 2021 and quarterly solar deployment levels stand at less than 20% of that figure.</p>\n<p>Product Progress: Solar Roof Still Not Ready For Prime Time</p>\n<p>Unveiled with great fanfare in October 2016,the Solar Roof was touted from the start as the future of solar energy technology. At the time, CEO Elon Musk was insistent that the Solar Roof was not merely a concept in development, but was actually a fully functional technology ready to enter full-scale production. Musk told his rapt audience that the acquisition of SolarCity would facilitate the rapid rollout of the Solar Roof, providing one of the first public justifications for the merger between Tesla and the virtually insolvent solar installer that had been founded by two of Musk's cousins, and of which Musk was then chairman of the board of directors.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e0e6430233a156f81e842006c4eac751\" tg-width=\"640\" tg-height=\"302\" width=\"100%\" height=\"auto\"><span>Source: Tesla Inc.</span></p>\n<p>The Solar Roof unveiling event may have helped smooth the way for the SolarCity tie-up, but it did so at the price of full transparency about the technology's readiness. Musk's claim about the Solar Roof's immediate viability was proven false in short order, as it quickly became apparent that the Solar Roof was still very much a concept in development, and with little near-term prospect of commercialization. Even then, few could have guessed how long that design and development process would take.</p>\n<p>A review of the progress to date on the long-promised but oft-delayed Solar Roof reveals a business reality far different from what has long been promised by Tesla’s solar cheerleaders. In the years since it was unveiled, the Solar Roof has gone through multipleredesigns and rebrands, even as Musk has repeatedly assured investors and the public that full-scale commercial production was imminent. In March 2019, he declared that 2019 would be \"the Year of the Solar Roof.\" In July of the same year, Musk tweeted that Solar Roof production wasaccelerating toward 1,000 units roofs per week:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6bbff17a88092785ef1227e94c6e8f19\" tg-width=\"640\" tg-height=\"251\" width=\"100%\" height=\"auto\"><span>Source: Elon Musk; Twitter</span></p>\n<p>This claim raised plenty of eyebrows in the investment community. Their skepticism proved well deserved as it soon became apparent that the actual Solar Roof production and installation rates were far lower. Even Electrek, a website well known for its consistently bullish Tesla commentary, felt compelled to call Musk out on his claim. According to Electrek, Musk's tweet was \"a bit of an exaggeration\" and that the actual production rate at the time was closer to 500 Solar Roofs per week. However, even that reduced projection appears to overstate the level of steady-state production and installation by a significant margin.</p>\n<p>The Solar Roof has seen its fortunes improve little in 2021 thus far. According to renewable energy industry journalist Eric Wesoff, Tesla had&nbsp;yet to install 1,000 Solar Roofs total&nbsp;as recently as this April. This pessimistic view was further reinforced last month when the Wall Street Journal&nbsp;reported&nbsp;that the Securities and Exchange Commission had already confronted Tesla over Musk's dubious prior Solar Roof claims:</p>\n<blockquote>\n “In correspondence sent to Tesla in 2019 and 2020, the SEC said tweets Mr. Musk wrote about Tesla’s solar roof production volumes and its stock price hadn’t undergone the required preapproval by Tesla’s lawyers. The communications, which haven’t been previously reported, spotlight the running tension between the nation’s top corporate regulator and Mr. Musk, who publicly mocked the SEC even after settling fraud claims with the agency. The SEC told Tesla in May 2020 that the company had failed ‘to enforce these procedures and controls despite repeated violations by Mr. Musk.’ The letter, signed by Steven Buchholz, a senior SEC official in its San Francisco office, added: ‘Tesla has abdicated the duties required of it by the court’s order.’\"\n</blockquote>\n<p>Whether installation speed has picked up meaningfully over the past few months is unclear thanks in no small part to Tesla's inconsistency with regard to reporting on the subject. Thus, while Tesla's Q1 investor letter boasted that Solar Roof installations \"grew 9x compared to the same period last year,\" it neglected to provide an exact number of MW deployed. The Q2 update offered still less clarity, failing to mention even the growth rate other than to say that deployments \"grew substantially\" on a sequential and year-over-year basis.</p>\n<p><b>Investor's Eye View</b></p>\n<p>Whatever way you slice it, Tesla’s seemingly endless struggle to launch a viable solar roof product at scale is problematic for a company that is valued based on a highly optimistic growth narrative. Tesla's market capitalization, which currently stands in excess of $670 billion, is nearly five times greater than that of Volkswagen AG (OTCPK:VWAGY), the world's largest automaker. That is in spite of the fact that Tesla currently has barely 5% of Volkswagen's annual automotive production capacity. In other words, Tesla is currently priced as if it will not only surpass the likes of Volkswagen in terms of production and sales volume, but will radically exceed them.</p>\n<p>While irrational exuberance about an EV-dominated future can explain some of Tesla's eye-watering share price, it is not the only factor. Tesla's valuation is also the result of the company's efforts to position itself as \"more than a car company.\" Solar has always been a core component of this narrative, yet it has failed to live up to the hype. Deployments remain far below the highs set half a decade ago, even as&nbsp;customer satisfaction&nbsp;has continued to fall.</p>\n<p>Moreover, the fundamental economics of Tesla's solar operations have always been shaky at best. Indeed, even as Tesla's automotive operations have inched toward breakeven, the&nbsp;margins for its solar business remain painfully negative. That is hardly a glowing endorsement of a business unit that is supposed to add to Tesla's value proposition, not detract from it.</p>\n<p>In sum, Tesla's valuation is the product of high expectations and belief in the company's ability to expand its offerings far beyond the conventional automotive realm. Based on the performance of its solar energy business to date, it would seem prudent to revise some of those expectations downward.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inside The Deterioration Of Tesla's Solar Business</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInside The Deterioration Of Tesla's Solar Business\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-24 11:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4451383-inside-the-deterioration-of-teslas-solar-business><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nTesla's $670 billion market cap is based in part on the belief that it is \"more than a car company\"; Tesla's solar energy business has fed this narrative.\nWhile treated like a value-add by ...</p>\n\n<a href=\"https://seekingalpha.com/article/4451383-inside-the-deterioration-of-teslas-solar-business\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://seekingalpha.com/article/4451383-inside-the-deterioration-of-teslas-solar-business","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1187997976","content_text":"Summary\n\nTesla's $670 billion market cap is based in part on the belief that it is \"more than a car company\"; Tesla's solar energy business has fed this narrative.\nWhile treated like a value-add by Tesla's boosters, its solar unit has in practice been a costly millstone; margins remain deeply negative.\nTesla's solar deployments have fallen far from highs set years ago, with little prospect of a reversal.\nHopes that Tesla's Solar Roof could reinvigorate deployment rates have faded amid multi-year delays and persistent installation bottlenecks.\nAs Tesla's solar business fades, it may threaten the company's broader growth narrative, as well as its vaunted share price.\n\nRoschetzkyIstockPhoto/iStock Editorial via Getty Images\nAs any of my longtime readers can undoubtedly attest, I have been tracking Tesla Inc. (NASDAQ:TSLA) for a while. I have covered numerous subjects related to the electric vehicle (“EV”) company over the years, but I have returned often to one in particular: Tesla’s solar energy business.\nIt has been a while since I lasttook a look under the hoodof Tesla’s solar division. With the first two quarters of 2021 in the rearview mirror, it feels like now is a good time to revisit the long-struggling business unit.\nMuch has changed for Tesla Solar in 2021, little of it for the good. Let’s discuss why this is the case.\nSolar Deployments In H1 2021: Still In A Long-Term Downtrend\nAs I have discussed at length on numerous occasions over the years, Tesla Solar has been in material multi-year decline from a deployments perspective. Thus, when Tesla reported Q1 2021 earnings, I naturally looked to the solar deployment numbers to see if the negative pattern had continued. As it turned out, Tesla had managed to achieve a major sequential jump in deployments, a fact the company was quick tocrow about in its Q1 investor letter:\n\n “Solar Retrofit and Solar Roof Solar deployments reached 92 MW in Q1, our strongest quarter in 2.5 years. Solar Roof deployments grew 9x compared to the same period last year.”\n\nTesla reported solar deployments to the tune of 92 megawatts (“MW”) in Q1, the most it had managed in years. Under the circumstances, Tesla can hardly be blamed for having wanted to highlight such a marked improvement in chart form:\nSource: Tesla Inc.\nThe chart above, which was included in the Q1 investor letter, certainly looks like it could be a sign of a turnaround in the making. However, its relatively limited timescale also limits its usefulness to investors and analysts interested in understanding the long-term performance and trajectory of Tesla's solar business. Charting the full history of Tesla's quarterly solar deployments through Q1 2021 offers a rather different perspective:\nSource: Author; Tesla Inc.\nI hardly have to remind investors that one quarter of growth does not a pattern make. If Tesla could sustain that growth into Q2, then one might be able to talk legitimately about a turnaround. As it turned out, Tesladeployed just 85 MW in Q2, a more than7.5% sequential drop:\nSource: TeslaCharts; Tesla Inc.\nTesla's solar deployments were not just lower in Q2 than in Q1, however. At 85MW, Tesla actually managed one 1MW less than it did in Q4 2020, despite seasonal impacts traditionally weakening year-end solar deployment rates. That would seem to put paid to any notion that Tesla's solar operations have been making a significant or sustainable turnaround.\nDeployments may have climbed significantly from their nadir in the first half of last year, but they remain a pale shadow of what Tesla was managing five years ago. They are also radically lower than what Tesla itself hadprojected in 2016when it was in the process of acquiring SolarCity:\nSource: @C_S_Skeptic; GLJ Research; Tesla Inc.\nIn 2016, Tesla was predicting solar deployments in excess of 500MW per quarter starting in 2017. We are now mid-way through 2021 and quarterly solar deployment levels stand at less than 20% of that figure.\nProduct Progress: Solar Roof Still Not Ready For Prime Time\nUnveiled with great fanfare in October 2016,the Solar Roof was touted from the start as the future of solar energy technology. At the time, CEO Elon Musk was insistent that the Solar Roof was not merely a concept in development, but was actually a fully functional technology ready to enter full-scale production. Musk told his rapt audience that the acquisition of SolarCity would facilitate the rapid rollout of the Solar Roof, providing one of the first public justifications for the merger between Tesla and the virtually insolvent solar installer that had been founded by two of Musk's cousins, and of which Musk was then chairman of the board of directors.\nSource: Tesla Inc.\nThe Solar Roof unveiling event may have helped smooth the way for the SolarCity tie-up, but it did so at the price of full transparency about the technology's readiness. Musk's claim about the Solar Roof's immediate viability was proven false in short order, as it quickly became apparent that the Solar Roof was still very much a concept in development, and with little near-term prospect of commercialization. Even then, few could have guessed how long that design and development process would take.\nA review of the progress to date on the long-promised but oft-delayed Solar Roof reveals a business reality far different from what has long been promised by Tesla’s solar cheerleaders. In the years since it was unveiled, the Solar Roof has gone through multipleredesigns and rebrands, even as Musk has repeatedly assured investors and the public that full-scale commercial production was imminent. In March 2019, he declared that 2019 would be \"the Year of the Solar Roof.\" In July of the same year, Musk tweeted that Solar Roof production wasaccelerating toward 1,000 units roofs per week:\nSource: Elon Musk; Twitter\nThis claim raised plenty of eyebrows in the investment community. Their skepticism proved well deserved as it soon became apparent that the actual Solar Roof production and installation rates were far lower. Even Electrek, a website well known for its consistently bullish Tesla commentary, felt compelled to call Musk out on his claim. According to Electrek, Musk's tweet was \"a bit of an exaggeration\" and that the actual production rate at the time was closer to 500 Solar Roofs per week. However, even that reduced projection appears to overstate the level of steady-state production and installation by a significant margin.\nThe Solar Roof has seen its fortunes improve little in 2021 thus far. According to renewable energy industry journalist Eric Wesoff, Tesla had yet to install 1,000 Solar Roofs total as recently as this April. This pessimistic view was further reinforced last month when the Wall Street Journal reported that the Securities and Exchange Commission had already confronted Tesla over Musk's dubious prior Solar Roof claims:\n\n “In correspondence sent to Tesla in 2019 and 2020, the SEC said tweets Mr. Musk wrote about Tesla’s solar roof production volumes and its stock price hadn’t undergone the required preapproval by Tesla’s lawyers. The communications, which haven’t been previously reported, spotlight the running tension between the nation’s top corporate regulator and Mr. Musk, who publicly mocked the SEC even after settling fraud claims with the agency. The SEC told Tesla in May 2020 that the company had failed ‘to enforce these procedures and controls despite repeated violations by Mr. Musk.’ The letter, signed by Steven Buchholz, a senior SEC official in its San Francisco office, added: ‘Tesla has abdicated the duties required of it by the court’s order.’\"\n\nWhether installation speed has picked up meaningfully over the past few months is unclear thanks in no small part to Tesla's inconsistency with regard to reporting on the subject. Thus, while Tesla's Q1 investor letter boasted that Solar Roof installations \"grew 9x compared to the same period last year,\" it neglected to provide an exact number of MW deployed. The Q2 update offered still less clarity, failing to mention even the growth rate other than to say that deployments \"grew substantially\" on a sequential and year-over-year basis.\nInvestor's Eye View\nWhatever way you slice it, Tesla’s seemingly endless struggle to launch a viable solar roof product at scale is problematic for a company that is valued based on a highly optimistic growth narrative. Tesla's market capitalization, which currently stands in excess of $670 billion, is nearly five times greater than that of Volkswagen AG (OTCPK:VWAGY), the world's largest automaker. That is in spite of the fact that Tesla currently has barely 5% of Volkswagen's annual automotive production capacity. In other words, Tesla is currently priced as if it will not only surpass the likes of Volkswagen in terms of production and sales volume, but will radically exceed them.\nWhile irrational exuberance about an EV-dominated future can explain some of Tesla's eye-watering share price, it is not the only factor. Tesla's valuation is also the result of the company's efforts to position itself as \"more than a car company.\" Solar has always been a core component of this narrative, yet it has failed to live up to the hype. Deployments remain far below the highs set half a decade ago, even as customer satisfaction has continued to fall.\nMoreover, the fundamental economics of Tesla's solar operations have always been shaky at best. Indeed, even as Tesla's automotive operations have inched toward breakeven, the margins for its solar business remain painfully negative. That is hardly a glowing endorsement of a business unit that is supposed to add to Tesla's value proposition, not detract from it.\nIn sum, Tesla's valuation is the product of high expectations and belief in the company's ability to expand its offerings far beyond the conventional automotive realm. Based on the performance of its solar energy business to date, it would seem prudent to revise some of those expectations downward.","news_type":1},"isVote":1,"tweetType":1,"viewCount":60,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":850604980,"gmtCreate":1634586078839,"gmtModify":1634608846648,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577554594597387","authorIdStr":"3577554594597387"},"themes":[],"htmlText":"Did they mention UBS is shorting SPCE when they tell investors to sell?&nbsp;","listText":"Did they mention UBS is shorting SPCE when they tell investors to sell?&nbsp;","text":"Did they mention UBS is shorting SPCE when they tell investors to sell?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850604980","repostId":"2176798122","repostType":2,"repost":{"id":"2176798122","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1634576220,"share":"https://www.laohu8.com/m/news/2176798122?lang=&edition=full","pubTime":"2021-10-19 00:57","market":"hk","language":"en","title":"Sell Virgin Galactic's stock after another long flight delay, UBS said","url":"https://stock-news.laohu8.com/highlight/detail?id=2176798122","media":"Dow Jones","summary":"MW Sell Virgin Galactic's stock after another long flight delay, UBS said\n\n\n  Tomi Kilgore \n\n\n  In f","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Sell Virgin Galactic's stock after another long flight delay, UBS said\n</p>\n<p>\n  Tomi Kilgore \n</p>\n<p>\n  In five months, Analyst Myles Walton has swung to bearish from bullish while the stock had gone full circle \n</p>\n<p>\n  Shares of Virgin Galactic dove Monday toward a five-month low, after UBS analyst Myles Walton recommended investors sell, after another \"long pushout\" of revenue-generating test flights was announced just weeks before of a large chuck of shares becomes available for sale. \n</p>\n<p>\n  Walton downgraded the space-tourism company to sell, after being at neutral since July 5. He slashed his stock price target by 42%, to $15 from $26. The new target implied a further 24% downside from current levels. \n</p>\n<p>\n  The stock <a href=\"https://laohu8.com/S/SPCE\">$(SPCE)$</a> dropped as much as 5.0% to an intraday low of $19.00, before paring some losses to be down 1.2% in midday trading. It has now shed 64.6% since closing at a four-month high of $55.91 on June 25. \n</p>\n<p>\n  The downgrade comes <a href=\"https://laohu8.com/S/AONE.U\">one</a> session after the stock tumbled 16.8%, following the company's announcement that commercial space flights would not begin until late 2022 after an issue with some materials was found. Walton noted that announcement was made just about a month after the company had delayed a powered flight to late October from late September because of a supplier part issue. \n</p>\n<p>\n  Don't miss: Virgin Galactic announces another delay, and the stock is plunging. \n</p>\n<p>\n  Walton said that although the company is certainly taking the right step to keep safety first, the \"starts and stops\" of flights, coupled with longer turn times of current generation spaceships shows the difficulty in providing investors with predictable and reliable operations. \n</p>\n<p>\n  \"The event path for the stock is now disjointed for the better part of the next year, and with 24% of shares outstanding (32% of the float) exiting their lockup period at the end of the month we expect further pressure ahead for the stock,\" Walton wrote in a note to clients. \n</p>\n<p>\n  Walton has now swung from bullish to bearish on the stock in five months, over a time that the stock had nearly tripled then lost all of those gains, and then some. \n</p>\n<p>\n  He had downgraded the stock to neutral from buy on July 6, while raising his price target to $45 from $36, citing valuation after the stock had more than doubled in a little over a month. That followed Walton's upgrade of the stock to buy from neutral on May 20, but trimmed his price target to $36 from $40, saying that valuation was now attractive as investor fears over test-flight delays and competitive pressures were overblown. \n</p>\n<p>\n  The fact that most of the remaining insider stakes were locked up through October was another reason to be bullish. (A lockup refers to an agreement by insiders not to sell the shares they own for a previously agreed upon time.) \n</p>\n<p>\n  Interestingly, the stock closed on the day Walton turned bullish at $19.81, or just 0.2% above current levels. \n</p>\n<p>\n  In Monday's note, he said with the start of commercial operations pushed out to the fourth quarter of 2022, it moves the cumulative delay to 2 1/2 years from the mid-2020 target the company had when it went public two years ago. \n</p>\n<p>\n  \"With a cumulative delay longer than the time the company has been public, it'll be a challenge to get too optimistic on flight cadence, and we've further lowered our outyear trajectory,\" Walton wrote. \n</p>\n<p>\n  The stock has now tumbled 34.5% over the past three months, and has shed 11.9% over the past 12 months. In comparison, the S&amp;P 500 index  has gained 3.5% the past three months and soared 28.6% the past year. \n</p>\n<p>\n  -Tomi Kilgore \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  October 18, 2021 12:57 ET (16:57 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sell Virgin Galactic's stock after another long flight delay, UBS said</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSell Virgin Galactic's stock after another long flight delay, UBS said\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-10-19 00:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Sell Virgin Galactic's stock after another long flight delay, UBS said\n</p>\n<p>\n  Tomi Kilgore \n</p>\n<p>\n  In five months, Analyst Myles Walton has swung to bearish from bullish while the stock had gone full circle \n</p>\n<p>\n  Shares of Virgin Galactic dove Monday toward a five-month low, after UBS analyst Myles Walton recommended investors sell, after another \"long pushout\" of revenue-generating test flights was announced just weeks before of a large chuck of shares becomes available for sale. \n</p>\n<p>\n  Walton downgraded the space-tourism company to sell, after being at neutral since July 5. He slashed his stock price target by 42%, to $15 from $26. The new target implied a further 24% downside from current levels. \n</p>\n<p>\n  The stock <a href=\"https://laohu8.com/S/SPCE\">$(SPCE)$</a> dropped as much as 5.0% to an intraday low of $19.00, before paring some losses to be down 1.2% in midday trading. It has now shed 64.6% since closing at a four-month high of $55.91 on June 25. \n</p>\n<p>\n  The downgrade comes <a href=\"https://laohu8.com/S/AONE.U\">one</a> session after the stock tumbled 16.8%, following the company's announcement that commercial space flights would not begin until late 2022 after an issue with some materials was found. Walton noted that announcement was made just about a month after the company had delayed a powered flight to late October from late September because of a supplier part issue. \n</p>\n<p>\n  Don't miss: Virgin Galactic announces another delay, and the stock is plunging. \n</p>\n<p>\n  Walton said that although the company is certainly taking the right step to keep safety first, the \"starts and stops\" of flights, coupled with longer turn times of current generation spaceships shows the difficulty in providing investors with predictable and reliable operations. \n</p>\n<p>\n  \"The event path for the stock is now disjointed for the better part of the next year, and with 24% of shares outstanding (32% of the float) exiting their lockup period at the end of the month we expect further pressure ahead for the stock,\" Walton wrote in a note to clients. \n</p>\n<p>\n  Walton has now swung from bullish to bearish on the stock in five months, over a time that the stock had nearly tripled then lost all of those gains, and then some. \n</p>\n<p>\n  He had downgraded the stock to neutral from buy on July 6, while raising his price target to $45 from $36, citing valuation after the stock had more than doubled in a little over a month. That followed Walton's upgrade of the stock to buy from neutral on May 20, but trimmed his price target to $36 from $40, saying that valuation was now attractive as investor fears over test-flight delays and competitive pressures were overblown. \n</p>\n<p>\n  The fact that most of the remaining insider stakes were locked up through October was another reason to be bullish. (A lockup refers to an agreement by insiders not to sell the shares they own for a previously agreed upon time.) \n</p>\n<p>\n  Interestingly, the stock closed on the day Walton turned bullish at $19.81, or just 0.2% above current levels. \n</p>\n<p>\n  In Monday's note, he said with the start of commercial operations pushed out to the fourth quarter of 2022, it moves the cumulative delay to 2 1/2 years from the mid-2020 target the company had when it went public two years ago. \n</p>\n<p>\n  \"With a cumulative delay longer than the time the company has been public, it'll be a challenge to get too optimistic on flight cadence, and we've further lowered our outyear trajectory,\" Walton wrote. \n</p>\n<p>\n  The stock has now tumbled 34.5% over the past three months, and has shed 11.9% over the past 12 months. In comparison, the S&amp;P 500 index  has gained 3.5% the past three months and soared 28.6% the past year. \n</p>\n<p>\n  -Tomi Kilgore \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  October 18, 2021 12:57 ET (16:57 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"USB":"美国合众银行","SPCE":"维珍银河"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176798122","content_text":"MW Sell Virgin Galactic's stock after another long flight delay, UBS said\n\n\n  Tomi Kilgore \n\n\n  In five months, Analyst Myles Walton has swung to bearish from bullish while the stock had gone full circle \n\n\n  Shares of Virgin Galactic dove Monday toward a five-month low, after UBS analyst Myles Walton recommended investors sell, after another \"long pushout\" of revenue-generating test flights was announced just weeks before of a large chuck of shares becomes available for sale. \n\n\n  Walton downgraded the space-tourism company to sell, after being at neutral since July 5. He slashed his stock price target by 42%, to $15 from $26. The new target implied a further 24% downside from current levels. \n\n\n  The stock $(SPCE)$ dropped as much as 5.0% to an intraday low of $19.00, before paring some losses to be down 1.2% in midday trading. It has now shed 64.6% since closing at a four-month high of $55.91 on June 25. \n\n\n  The downgrade comes one session after the stock tumbled 16.8%, following the company's announcement that commercial space flights would not begin until late 2022 after an issue with some materials was found. Walton noted that announcement was made just about a month after the company had delayed a powered flight to late October from late September because of a supplier part issue. \n\n\n  Don't miss: Virgin Galactic announces another delay, and the stock is plunging. \n\n\n  Walton said that although the company is certainly taking the right step to keep safety first, the \"starts and stops\" of flights, coupled with longer turn times of current generation spaceships shows the difficulty in providing investors with predictable and reliable operations. \n\n\n  \"The event path for the stock is now disjointed for the better part of the next year, and with 24% of shares outstanding (32% of the float) exiting their lockup period at the end of the month we expect further pressure ahead for the stock,\" Walton wrote in a note to clients. \n\n\n  Walton has now swung from bullish to bearish on the stock in five months, over a time that the stock had nearly tripled then lost all of those gains, and then some. \n\n\n  He had downgraded the stock to neutral from buy on July 6, while raising his price target to $45 from $36, citing valuation after the stock had more than doubled in a little over a month. That followed Walton's upgrade of the stock to buy from neutral on May 20, but trimmed his price target to $36 from $40, saying that valuation was now attractive as investor fears over test-flight delays and competitive pressures were overblown. \n\n\n  The fact that most of the remaining insider stakes were locked up through October was another reason to be bullish. (A lockup refers to an agreement by insiders not to sell the shares they own for a previously agreed upon time.) \n\n\n  Interestingly, the stock closed on the day Walton turned bullish at $19.81, or just 0.2% above current levels. \n\n\n  In Monday's note, he said with the start of commercial operations pushed out to the fourth quarter of 2022, it moves the cumulative delay to 2 1/2 years from the mid-2020 target the company had when it went public two years ago. \n\n\n  \"With a cumulative delay longer than the time the company has been public, it'll be a challenge to get too optimistic on flight cadence, and we've further lowered our outyear trajectory,\" Walton wrote. \n\n\n  The stock has now tumbled 34.5% over the past three months, and has shed 11.9% over the past 12 months. In comparison, the S&P 500 index  has gained 3.5% the past three months and soared 28.6% the past year. \n\n\n  -Tomi Kilgore \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  October 18, 2021 12:57 ET (16:57 GMT)\n\n\n  Copyright (c) 2021 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":505,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":890203730,"gmtCreate":1628118313920,"gmtModify":1628128189095,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577554594597387","authorIdStr":"3577554594597387"},"themes":[],"htmlText":"Ummmm so I brought puts on CCL because Delta was spreading—— and then it rallied up 16% in the 2days after&nbsp;","listText":"Ummmm so I brought puts on CCL because Delta was spreading—— and then it rallied up 16% in the 2days after&nbsp;","text":"Ummmm so I brought puts on CCL because Delta was spreading—— and then it rallied up 16% in the 2days after","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/890203730","repostId":"2156106357","repostType":4,"isVote":1,"tweetType":1,"viewCount":264,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":169634932,"gmtCreate":1623832170126,"gmtModify":1623832217121,"author":{"id":"3577554594597387","authorId":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577554594597387","authorIdStr":"3577554594597387"},"themes":[],"htmlText":"Hurry up I have call options expiring","listText":"Hurry up I have call options expiring","text":"Hurry up I have call options expiring","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/169634932","repostId":"2143075116","repostType":2,"isVote":1,"tweetType":1,"viewCount":129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}